TY 2018 Form 990

(A) Name and Title	(B) Average hours per week (list any hours for related organizations below dotted line)	(C) Position (do not check more than one box, unless person is both an officer and a director/trustee)	(E) Reportable compensation from related organizations (W- 2/1099-MISC)
(1) JOHN T TIGHE III...................................................................... CHAIR	1.00 ................. 0.00	X	X			0	0	0
(2) R EDWARD HOWELL...................................................................... VICE CHAIR	1.00 ................. 0.00	X	X			0	0	0
(3) PAUL W ABRAMOWITZ...................................................................... PRESIDENT/ASHP CEO	1.00 ................. 39.00	X	X			0	869,957	53,974
(4) THOMAS J JOHNSON...................................................................... TREASURER	1.00 ................. 0.00	X	X			0	0	0
(5) STEVEN A RUBLOFF...................................................................... SECY/ASHP REF CEO	40.00 ................. 0.00	X	X			302,292	0	32,017
(6) KELLY M SMITH...................................................................... DIRECTOR AT LARGE	1.00 ................. 0.00	X				0	10,150	0
(7) MINNIE BAYLOR-HENRY...................................................................... DIRECTOR AT LARGE	1.00 ................. 0.00	X				0	0	0
(8) LISA M GERSEMA...................................................................... DIRECTOR AT LARGE	1.00 ................. 0.00	X				0	10,150	0
(9) JANET L MIGHTY...................................................................... DIRECTOR AT LARGE	1.00 ................. 0.00	X				0	0	0
(10) KEN PEREZ...................................................................... DIRECTOR AT LARGE	1.00 ................. 0.00	X				0	0	0
(11) SCOTT M SAMSON...................................................................... DIRECTOR AT LARGE	1.00 ................. 0.00	X				0	0	0
(12) ROGER W ANDERSON...................................................................... DIRECTOR AT LARGE	1.00 ................. 0.00	X				0	0	0
(13) BARBARA NUSSBAUM...................................................................... VICE PRESIDENT	40.00 ................. 0.00			X		172,500	0	52,942
(14) BETHANY COULTER...................................................................... DIR. OF STRATEGIC COMM (THRU 12/18)	40.00 ................. 0.00			X		133,774	0	24,584
(15) STEPHANIE BROWN...................................................................... DIRECTOR OF PROGRAMS	40.00 ................. 0.00			X		110,022	0	22,332
(16) STEPHEN J ALLEN...................................................................... FORMER SECY/ASHP REF CEO (THRU 2/18)	0.00 ................. 0.00				X	67,938	0	19,489

- TIN:

SCHEDULE A
(Form 990 or 990EZ)

Department of the Treasury
Internal Revenue Service

Public Charity Status and Public Support

Complete if the organization is a section 501(c)(3) organization or a section 4947(a)(1) nonexempt charitable trust.
right arrow

Attach to Form 990 or Form 990-EZ.
right arrow

Go to www.irs.gov/Form990 for the latest information.

OMB No. 1545-0047

2018

Open to Public
Inspection

Name of the organization

AMERICAN SOCIETY OF HEALTH-SYSTEM
PHARMACISTS RESEARCH AND EDUCATION FDTN

Employer identification number

23-7033369

Part I

Reason for Public Charity Status (All organizations must complete this part.) See instructions.

The organization is not a private foundation because it is: (For lines 1 through 12, check only one box.)

A church, convention of churches, or association of churches described in section 170(b)(1)(A)(i).

A school described in section 170(b)(1)(A)(ii). (Attach Schedule E (Form 990 or 990-EZ).)

A hospital or a cooperative hospital service organization described in section 170(b)(1)(A)(iii).

A medical research organization operated in conjunction with a hospital described in section 170(b)(1)(A)(iii). Enter the hospital's name, city, and state:

An organization operated for the benefit of a college or university owned or operated by a governmental unit described in section 170(b)(1)(A)(iv). (Complete Part II.)

A federal, state, or local government or governmental unit described in section 170(b)(1)(A)(v).

An organization that normally receives a substantial part of its support from a governmental unit or from the general public described in section 170(b)(1)(A)(vi). (Complete Part II.)

A community trust described in section 170(b)(1)(A)(vi). (Complete Part II.)

An agricultural research organization described in 170(b)(1)(A)(ix) operated in conjunction with a land-grant college or university or a non-land grant college of agriculture. See instructions. Enter the name, city, and state of the college or university:

An organization that normally receives: (1) more than 331/3% of its support from contributions, membership fees, and gross receipts from activities related to its exempt functions—subject to certain exceptions, and (2) no more than 331/3% of its support from gross investment income and unrelated business taxable income (less section 511 tax) from businesses acquired by the organization after June 30, 1975. See section 509(a)(2). (Complete Part III.)

An organization organized and operated exclusively to test for public safety. See section 509(a)(4).

An organization organized and operated exclusively for the benefit of, to perform the functions of, or to carry out the purposes of one or more publicly supported organizations described in section 509(a)(1) or section 509(a)(2). See section 509(a)(3). Check the box in lines 12a through 12d that describes the type of supporting organization and complete lines 12e, 12f, and 12g.

Type I. A supporting organization operated, supervised, or controlled by its supported organization(s), typically by giving the supported organization(s) the power to regularly appoint or elect a majority of the directors or trustees of the supporting organization. You must complete Part IV, Sections A and B.

Type II. A supporting organization supervised or controlled in connection with its supported organization(s), by having control or management of the supporting organization vested in the same persons that control or manage the supported organization(s). You must complete Part IV, Sections A and C.

Type III functionally integrated. A supporting organization operated in connection with, and functionally integrated with, its supported organization(s) (see instructions). You must complete Part IV, Sections A, D, and E.

Type III non-functionally integrated. A supporting organization operated in connection with its supported organization(s) that is not functionally integrated. The organization generally must satisfy a distribution requirement and an attentiveness requirement (see instructions). You must complete Part IV, Sections A and D, and Part V.

Check this box if the organization received a written determination from the IRS that it is a Type I, Type II, Type III functionally integrated, or Type III non-functionally integrated supporting organization.

Enter the number of supported organizations ...............................

Provide the following information about the supported organization(s).

(i) Name of supported organization	(ii) EIN	(iv) Is the organization listed in your governing document?		(v) Amount of monetary support (see instructions)	(vi) Amount of other support (see instructions)
(i) Name of supported organization	(ii) EIN	Yes	No	(v) Amount of monetary support (see instructions)	(vi) Amount of other support (see instructions)


Total

For Paperwork Reduction Act Notice, see the Instructions for
Form 990 or 990-EZ.

Cat. No. 11285F

Schedule A (Form 990 or 990-EZ) 2018

Page 2

Part II

Support Schedule for Organizations Described in Sections 170(b)(1)(A)(iv), 170(b)(1)(A)(vi), and 170(b)(1)(A)(ix)
(Complete only if you checked the box on line 5, 7, 8, or 9 of Part I or if the organization failed to qualify under Part III. If the organization fails to qualify under the tests listed below, please complete Part III.)

Section A. Public Support

Calendar year (or fiscal year beginning in)		(a) 2014	(b) 2015	(c) 2016	(d) 2017	(e) 2018	(f) Total
1	Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") ..	2,104,181	2,055,036	1,799,986	2,088,349	1,768,602	9,816,154
2	Tax revenues levied for the organization's benefit and either paid to or expended on its behalf....
3	The value of services or facilities furnished by a governmental unit to the organization without charge..
4	Total. Add lines 1 through 3	2,104,181	2,055,036	1,799,986	2,088,349	1,768,602	9,816,154
5	The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f)..						4,384,031
6	Public support. Subtract line 5 from line 4.						5,432,123

Section B. Total Support

Calendar year (or fiscal year beginning in)		(a) 2014	(b) 2015	(c) 2016	(d) 2017	(e) 2018	(f) Total
7	Amounts from line 4..	2,104,181	2,055,036	1,799,986	2,088,349	1,768,602	9,816,154
8	Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources...	331,180	294,198	270,016	315,175	406,338	1,616,907
9	Net income from unrelated business activities, whether or not the business is regularly carried on..
10	Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.)..
11	Total support. Add lines 7 through 10						11,433,061

Gross receipts from related activities, etc. (see instructions) ..................

2,949,734

First five years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a section 501(c)(3) organization, check this box and stop here........................................ right arrow

Section C. Computation of Public Support Percentage

Public support percentage for 2018 (line 6, column (f) divided by line 11, column (f)) .........

47.510 %

Public support percentage for 2017 Schedule A, Part II, line 14 ...............

45.460 %

16a

33 1/3% support test—2018. If the organization did not check the box on line 13, and line 14 is 33 1/3% or more, check this box
and stop here. The organization qualifies as a publicly supported organization ....................... right arrow

33 1/3% support test—2017. If the organization did not check a box on line 13 or 16a, and line 15 is 33 1/3% or more, check this
box and stop here. The organization qualifies as a publicly supported organization ..................... right arrow

17a

10%-facts-and-circumstances test—2018. If the organization did not check a box on line 13, 16a, or 16b, and line 14
is 10% or more, and if the organization meets the "facts-and-circumstances" test, check this box and stop here. Explain
in Part VI how the organization meets the "facts-and-circumstances" test. The organization qualifies as a publicly supported
organization ..................................................... right arrow

10%-facts-and-circumstances test—2017. If the organization did not check a box on line 13, 16a, 16b, or 17a, and line
15 is 10% or more, and if the organization meets the "facts-and-circumstances" test, check this box and stop here.
Explain in Part VI how the organization meets the "facts-and-circumstances" test. The organization qualifies as a publicly
supported organization ................................................ right arrow

Private foundation. If the organization did not check a box on line 13, 16a, 16b, 17a, or 17b, check this box and see
instructions ..................................................... right arrow

Schedule A (Form 990 or 990-EZ) 2018

Page 3

Part III

Support Schedule for Organizations Described in Section 509(a)(2)
(Complete only if you checked the box on line 10 of Part I or if the organization failed to qualify under Part II. If the organization fails to qualify under the tests listed below, please complete Part II.)

Section A. Public Support

Calendar year (or fiscal year beginning in)		(a) 2014	(b) 2015	(c) 2016	(d) 2017	(e) 2018	(f) Total
1	Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .
2	Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose
3	Gross receipts from activities that are not an unrelated trade or business under section 513 .....
4	Tax revenues levied for the organization's benefit and either paid to or expended on its behalf...
5	The value of services or facilities furnished by a governmental unit to the organization without charge
6	Total. Add lines 1 through 5
7a	Amounts included on lines 1, 2, and 3 received from disqualified persons
b	Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year.
c	Add lines 7a and 7b..
8	Public support. (Subtract line 7c from line 6.)

Section B. Total Support

Calendar year (or fiscal year beginning in)		(a) 2014	(b) 2015	(c) 2016	(d) 2017	(e) 2018	(f) Total
9	Amounts from line 6...
10a	Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources..
b	Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975.
c	Add lines 10a and 10b.
11	Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on.
12	Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) ..
13	Total support. (Add lines 9, 10c, 11, and 12.)..

First five years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a section 501(c)(3) organization,
check this box and stop here............................................. right arrow

Section C. Computation of Public Support Percentage

Public support percentage for 2018 (line 8, column (f) divided by line 13, column (f)) .........

Public support percentage from 2017 Schedule A, Part III, line 15 ...............

Section D. Computation of Investment Income Percentage

Investment income percentage for 2018 (line 10c, column (f) divided by line 13, column (f)) ......

Investment income percentage from 2017 Schedule A, Part III, line 17 .............

19a

331/3% support tests—2018. If the organization did not check the box on line 14, and line 15 is more than 33 1/3%, and line 17 is not more than 33 1/3%, check this box and stop here. The organization qualifies as a publicly supported organization ....... right arrow

33 1/3% support tests—2017. If the organization did not check a box on line 14 or line 19a, and line 16 is more than 33 1/3% and line 18 is not more than 33 1/3%, check this box and stop here. The organization qualifies as a publicly supported organization .... right arrow

Private foundation. If the organization did not check a box on line 14, 19a, or 19b, check this box and see instructions .... right arrow

Schedule A (Form 990 or 990-EZ) 2018

Page 4

Part IV

Supporting Organizations

(Complete only if you checked a box on line 12 of Part I. If you checked 12a of Part I, complete Sections A and B. If you checked 12b of Part I, complete Sections A and C. If you checked 12c of Part I, complete Sections A, D, and E. If you checked 12d of Part I, complete Sections A and D, and complete Part V.)

Section A. All Supporting Organizations

Yes

Are all of the organization’s supported organizations listed by name in the organization’s governing documents?
If "No," describe in Part VI how the supported organizations are designated. If designated by class or purpose,
describe the designation. If historic and continuing relationship, explain.

Did the organization have any supported organization that does not have an IRS determination of status under section 509(a)(1) or (2)? If "Yes," explain in Part VI how the organization determined that the supported organization was described in section 509(a)(1) or (2).

Did the organization have a supported organization described in section 501(c)(4), (5), or (6)? If "Yes," answer (b) and (c) below.

Did the organization confirm that each supported organization qualified under section 501(c)(4), (5), or (6) and satisfied the public support tests under section 509(a)(2)? If "Yes," describe in Part VI when and how the organization made the determination.

Did the organization ensure that all support to such organizations was used exclusively for section 170(c)(2)(B) purposes? If "Yes," explain in Part VI what controls the organization put in place to ensure such use.

Was any supported organization not organized in the United States ("foreign supported organization")? If “Yes” and if you checked 12a or 12b in Part I, answer (b) and (c) below.

Did the organization have ultimate control and discretion in deciding whether to make grants to the foreign supported organization? If “Yes,” describe in Part VI how the organization had such control and discretion despite being controlled or supervised by or in connection with its supported organizations.

Did the organization support any foreign supported organization that does not have an IRS determination under sections 501(c)(3) and 509(a)(1) or (2)? If “Yes,” explain in Part VI what controls the organization used to ensure that all support to the foreign supported organization was used exclusively for section 170(c)(2)(B) purposes.

Did the organization add, substitute, or remove any supported organizations during the tax year? If “Yes,” answer (b) and (c) below (if applicable). Also, provide detail in Part VI, including (i) the names and EIN numbers of the supported organizations added, substituted, or removed; (ii) the reasons for each such action; (iii) the authority under the organization's organizing document authorizing such action; and (iv) how the action was accomplished (such as by amendment to the organizing document).

Type I or Type II only. Was any added or substituted supported organization part of a class already designated in the organization's organizing document?

Substitutions only. Was the substitution the result of an event beyond the organization's control?

Did the organization provide support (whether in the form of grants or the provision of services or facilities) to anyone other than (i) its supported organizations, (ii) individuals that are part of the charitable class benefited by one or more of its supported organizations, or (iii) other supporting organizations that also support or benefit one or more of the filing organization’s supported organizations? If “Yes,” provide detail in Part VI.

Did the organization provide a grant, loan, compensation, or other similar payment to a substantial contributor (defined in section 4958(c)(3)(C)), a family member of a substantial contributor, or a 35% controlled entity with regard to a substantial contributor? If “Yes,” complete Part I of Schedule L (Form 990 or 990-EZ) .

Did the organization make a loan to a disqualified person (as defined in section 4958) not described in line 7? If “Yes,” complete Part I of Schedule L (Form 990 or 990-EZ).

Was the organization controlled directly or indirectly at any time during the tax year by one or more disqualified persons as defined in section 4946 (other than foundation managers and organizations described in section 509(a)(1) or (2))? If “Yes,” provide detail in Part VI.

Did one or more disqualified persons (as defined in line 9a) hold a controlling interest in any entity in which the supporting organization had an interest? If “Yes,” provide detail in Part VI.

Did a disqualified person (as defined in line 9a) have an ownership interest in, or derive any personal benefit from, assets in which the supporting organization also had an interest? If “Yes,” provide detail in Part VI.

10a

Was the organization subject to the excess business holdings rules of section 4943 because of section 4943(f) (regarding certain Type II supporting organizations, and all Type III non-functionally integrated supporting organizations)? If “Yes,” answer line 10b below.

10a

Did the organization have any excess business holdings in the tax year? (Use Schedule C, Form 4720, to determine whether the organization had excess business holdings).

10b

Schedule A (Form 990 or 990-EZ) 2018

Page 5

Part IV

Supporting Organizations (continued)

Yes

Has the organization accepted a gift or contribution from any of the following persons?

A person who directly or indirectly controls, either alone or together with persons described in (b) and (c) below, the governing body of a supported organization?

11a

A family member of a person described in (a) above?

11b

A 35% controlled entity of a person described in (a) or (b) above? If “Yes” to a, b, or c, provide detail in Part VI.

11c

Section B. Type I Supporting Organizations

Yes

Did the directors, trustees, or membership of one or more supported organizations have the power to regularly appoint or elect at least a majority of the organization’s directors or trustees at all times during the tax year? If “No,” describe in Part VI how the supported organization(s) effectively operated, supervised, or controlled the organization’s activities. If the organization had more than one supported organization, describe how the powers to appoint and/or remove directors or trustees were allocated among the supported organizations and what conditions or restrictions, if any, applied to such powers during the tax year.

Did the organization operate for the benefit of any supported organization other than the supported organization(s) that operated, supervised, or controlled the supporting organization? If “Yes,” explain in Part VI how providing such benefit carried out the purposes of the supported organization(s) that operated, supervised or controlled the supporting organization.

Section C. Type II Supporting Organizations

Yes

Were a majority of the organization’s directors or trustees during the tax year also a majority of the directors or trustees of each of the organization’s supported organization(s)? If “No,” describe in Part VI how control or management of the supporting organization was vested in the same persons that controlled or managed the supported organization(s).

Section D. All Type III Supporting Organizations

Yes

Did the organization provide to each of its supported organizations, by the last day of the fifth month of the organization’s tax year, (i) a written notice describing the type and amount of support provided during the prior tax year, (ii) a copy of the Form 990 that was most recently filed as of the date of notification, and (iii) copies of the organization’s governing documents in effect on the date of notification, to the extent not previously provided?

Were any of the organization’s officers, directors, or trustees either (i) appointed or elected by the supported organization(s) or (ii) serving on the governing body of a supported organization? If "No," explain in Part VI how the organization maintained a close and continuous working relationship with the supported organization(s).

By reason of the relationship described in (2), did the organization’s supported organizations have a significant voice in the organization’s investment policies and in directing the use of the organization’s income or assets at all times during the tax year? If "Yes," describe in Part VI the role the organization’s supported organizations played in this regard.

Section E. Type III Functionally-Integrated Supporting Organizations

Check the box next to the method that the organization used to satisfy the Integral Part Test during the year (see instructions):

The organization satisfied the Activities Test. Complete line 2 below.

The organization is the parent of each of its supported organizations. Complete line 3 below.

The organization supported a governmental entity. Describe in Part VI how you supported a government entity (see instructions)

Activities Test. Answer (a) and (b) below.

Yes

Did substantially all of the organization’s activities during the tax year directly further the exempt purposes of the supported organization(s) to which the organization was responsive? If "Yes," then in Part VI identify those supported organizations and explain how these activities directly furthered their exempt purposes, how the organization was responsive to those supported organizations, and how the organization determined that these activities constituted substantially all of its activities.

Did the activities described in (a) constitute activities that, but for the organization’s involvement, one or more of the organization’s supported organization(s) would have been engaged in? If "Yes," explain in Part VI the reasons for the organization’s position that its supported organization(s) would have engaged in these activities but for the organization’s involvement.

Parent of Supported Organizations. Answer (a) and (b) below.

Did the organization have the power to regularly appoint or elect a majority of the officers, directors, or trustees of each of the supported organizations? Provide details in Part VI.

Did the organization exercise a substantial degree of direction over the policies, programs and activities of each of its supported organizations? If "Yes," describe in Part VI. the role played by the organization in this regard.

Schedule A (Form 990 or 990-EZ) 2018

Page 6

Part V

Type III Non-Functionally Integrated 509(a)(3) Supporting Organizations

Check here if the organization satisfied the Integral Part Test as a qualifying trust on Nov. 20, 1970 (explain in Part VI). See instructions. All other Type III non-functionally integrated supporting organizations must complete Sections A through E.

	Section A - Adjusted Net Income		(A) Prior Year	(B) Current Year (optional)
1	Net short-term capital gain	1
2	Recoveries of prior-year distributions	2
3	Other gross income (see instructions)	3
4	Add lines 1 through 3	4
5	Depreciation and depletion	5
6	Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions)	6
7	Other expenses (see instructions)	7
8	Adjusted Net Income (subtract lines 5, 6 and 7 from line 4)	8

	Section B - Minimum Asset Amount		(A) Prior Year	(B) Current Year (optional)
1	Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year):	1
a	Average monthly value of securities	1a
b	Average monthly cash balances	1b
c	Fair market value of other non-exempt-use assets	1c
d	Total (add lines 1a, 1b, and 1c)	1d
e	Discount claimed for blockage or other factors (explain in detail in Part VI):
2	Acquisition indebtedness applicable to non-exempt use assets	2
3	Subtract line 2 from line 1d	3
4	Cash deemed held for exempt use. Enter 1-1/2% of line 3 (for greater amount, see instructions).	4
5	Net value of non-exempt-use assets (subtract line 4 from line 3)	5
6	Multiply line 5 by .035	6
7	Recoveries of prior-year distributions	7
8	Minimum Asset Amount (add line 7 to line 6)	8

	Section C - Distributable Amount		Current Year
1	Adjusted net income for prior year (from Section A, line 8, Column A)	1
2	Enter 85% of line 1	2
3	Minimum asset amount for prior year (from Section B, line 8, Column A)	3
4	Enter greater of line 2 or line 3	4
5	Income tax imposed in prior year	5
6	Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions)	6

Check here if the current year is the organization's first as a non-functionally-integrated Type III supporting organization (see instructions)

Schedule A (Form 990 or 990-EZ) 2018

Page 7

Part V

Type III Non-Functionally Integrated 509(a)(3) Supporting Organizations (continued)

Section D - Distributions		Current Year
1 Amounts paid to supported organizations to accomplish exempt purposes
2 Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity
3 Administrative expenses paid to accomplish exempt purposes of supported organizations
4 Amounts paid to acquire exempt-use assets
5 Qualified set-aside amounts (prior IRS approval required)
6 Other distributions (describe in Part VI). See instructions
7Total annual distributions. Add lines 1 through 6.
8 Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions
9 Distributable amount for 2018 from Section C, line 6
10 Line 8 amount divided by Line 9 amount

Section E - Distribution Allocations (see instructions)		(i) Excess Distributions	(ii) Underdistributions Pre-2018	(iii) Distributable Amount for 2018
1 Distributable amount for 2018 from Section C, line 6
2 Underdistributions, if any, for years prior to 2018 (reasonable cause required-- explain in Part VI). See instructions.
3 Excess distributions carryover, if any, to 2018:
a From 2013.......
b From 2014.......
c From 2015.......
d From 2016.......
e From 2017.......
fTotal of lines 3a through e
g Applied to underdistributions of prior years
h Applied to 2018 distributable amount
i Carryover from 2013 not applied (see instructions)
j Remainder. Subtract lines 3g, 3h, and 3i from 3f.
4Distributions for 2018 from Section D, line 7:
$
a Applied to underdistributions of prior years
b Applied to 2018 distributable amount
c Remainder. Subtract lines 4a and 4b from 4.
5 Remaining underdistributions for years prior to 2018, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions.
6 Remaining underdistributions for 2018. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions.
7 Excess distributions carryover to 2019. Add lines 3j and 4c.
8 Breakdown of line 7:
a Excess from 2014......
b Excess from 2015.....
c Excess from 2016.....
d Excess from 2017.....
e Excess from 2018.....

Schedule A (Form 990 or 990-EZ) (2018)

Schedule A (Form 990 or 990-EZ) 2018

Page 8

Part VI

Supplemental Information. Provide the explanations required by Part II, line 10; Part II, line 17a or 17b; Part III, line 12; Part IV, Section A, lines 1, 2, 3b, 3c, 4b, 4c, 5a, 6, 9a, 9b, 9c, 11a, 11b, and 11c; Part IV, Section B, lines 1 and 2; Part IV, Section C, line 1; Part IV, Section D, lines 2 and 3; Part IV, Section E, lines 1c, 2a, 2b, 3a and 3b; Part V, line 1; Part V, Section B, line 1e; Part V Section D, lines 5, 6, and 8; and Part V, Section E, lines 2, 5, and 6. Also complete this part for any additional information. (See instructions).

Facts And Circumstances Test

Return Reference	Explanation

Schedule A (Form 990 or 990-EZ) 2018

Additional Data

Software ID:
Software Version:

- TIN:

Schedule B
(Form 990, 990-EZ,
or 990-PF)

Department of the Treasury
Internal Revenue Service

Schedule of Contributors

Attach to Form 990, 990-EZ, or 990-PF.

Go to www.irs.gov/Form990 for the latest information.

OMB No. 1545-0047

2018

Name of the organization

AMERICAN SOCIETY OF HEALTH-SYSTEM
PHARMACISTS RESEARCH AND EDUCATION FDTN

Employer identification number

23-7033369

Organization type (check one):

Filers of:

Section:

Form 990 or 990-EZ

501(c)( ) (enter number) organization

4947(a)(1) nonexempt charitable trust not treated as a private foundation

527 political organization

Form 990-PF

501(c)(3) exempt private foundation

4947(a)(1) nonexempt charitable trust treated as a private foundation

501(c)(3) taxable private foundation

Check if your organization is covered by the General Rule or a Special Rule.
Note. Only a section 501(c)(7), (8), or (10) organization can check boxes for both the General Rule and a Special Rule. See instructions.

General Rule

For an organization filing Form 990, 990-EZ, or 990-PF that received, during the year, contributions totaling $5,000 or more (in money or other property) from any one contributor. Complete Parts I and II. See instructions for determining a contributor's total contributions.

Special Rules

For an organization described in section 501(c)(3) filing Form 990 or 990-EZ that met the 33¹/3% support test of the regulations
under sections 509(a)(1) and 170(b)(1)(A)(vi), that checked Schedule A (Form 990 or 990-EZ), Part II, line 13, 16a, or 16b, and that received from any one contributor, during the year, total contributions of the greater of (1) $5,000 or (2) 2% of the amount on (i) Form 990, Part VIII, line 1h, or (ii) Form 990-EZ, line 1. Complete Parts I and II.

For an organization described in section 501(c)(7), (8), or (10) filing Form 990 or 990-EZ that received from any one contributor,
during the year, total contributions of more than $1,000 exclusively for religious, charitable, scientific, literary, or educational purposes, or for the prevention of cruelty to children or animals. Complete Parts I, II, and III.

For an organization described in section 501(c)(7), (8), or (10) filing Form 990 or 990-EZ that received from any one contributor,
during the year, contributions exclusively for religious, charitable, etc., purposes, but no such contributions totaled more than $1,000. If this box is checked, enter here the total contributions that were received during the year for an exclusively religious, charitable, etc., purpose. Don't complete any of the parts unless the General Rule applies to this organization because it received nonexclusively religious, charitable, etc., contributions totaling $5,000 or more during the year ......... Arrow Bullet

Caution. An organization that isn't covered by the General Rule and/or the Special Rules doesn't file Schedule B (Form 990,
990-EZ, or 990-PF), but it must answer “No” on Part IV, line 2, of its Form 990; or check the box on line H of its
Form 990-EZ or on its Form 990PF, Part I, line 2, to certify that it doesn't meet the filing requirements of Schedule B (Form 990,
990-EZ, or 990-PF).

For Paperwork Reduction Act Notice, see the Instructions
for Form 990, 990-EZ, or 990-PF.

Cat. No. 30613XSchedule B (Form 990, 990-EZ, or 990-PF) (2018)

Schedule B (Form 990, 990-EZ, or 990-PF) (2018) Page 2

Name of organization AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION FDTN

Part I	Contributors (See instructions). Use duplicate copies of Part I if additional space is needed.
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
RESTRICTED	,	$ RESTRICTED	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
(a) No.	(b) Name, address, and ZIP + 4	(c) Total contributions	(d) Type of contribution
		$	Person Payroll Noncash (Complete Part II for noncash contributions.)
Schedule B (Form 990, 990-EZ, or 990-PF) (2018)

Schedule B (Form 990, 990-EZ, or 990-PF) (2018)

Page 3

Name of organization AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION FDTN		Employer identification number 23-7033369

Part II	Noncash Property (See instructions). Use duplicate copies of Part II if additional space is needed.
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (See instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (See instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (See instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (See instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (See instructions)	(d) Date received
		$
(a) No. from Part I	(b) Description of noncash property given	(c) FMV (or estimate) (See instructions)	(d) Date received
		$
Schedule B (Form 990, 990-EZ, or 990-PF) (2018)

Schedule B (Form 990, 990-EZ, or 990-PF) (2018)

Page 4


Name of organization AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION FDTN			Employer identification number 23-7033369
Part III Exclusively religious, charitable, etc., contributions to organizations described in section 501(c)(7), (8), or (10) that total more than $1,000 for the year from any one contributor. Complete columns (a) through (e) and the following line entry. For organizations completing Part III, enter the total of exclusively religious, charitable, etc., contributions of $1,000 or less for the year. (Enter this information once. See instructions.) $ Use duplicate copies of Part III if additional space is needed.

(a)
No. from Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a)
No. from Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a)
No. from Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

(a)
No. from Part I

(b) Purpose of gift

(d) Description of how gift is held

(e) Transfer of gift
Transferee's name, address, and ZIP 4	Relationship of transferor to transferee

Schedule B (Form 990, 990-EZ, or 990-PF) (2018)

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE D
(Form 990)

Department of the Treasury
Internal Revenue Service

Supplemental Financial Statements

Complete if the organization answered "Yes," on Form 990,
Part IV, line 6, 7, 8, 9, 10, 11a, 11b, 11c, 11d, 11e, 11f, 12a, or 12b.
SchDMd Bullet

Attach to Form 990.
SchDMd Bullet

Go to www.irs.gov/Form990 for the latest information.

OMB No. 1545-0047

2018

Open to Public Inspection

Name of the organization

AMERICAN SOCIETY OF HEALTH-SYSTEM
PHARMACISTS RESEARCH AND EDUCATION FDTN

Employer identification number

23-7033369

Part I

Organizations Maintaining Donor Advised Funds or Other Similar Funds or Accounts. Complete if the organization answered "Yes" on Form 990, Part IV, line 6.

		(a) Donor advised funds	(b) Funds and other accounts
1	Total number at end of year .........
2	Aggregate value of contributions to (during year)
3	Aggregate value of grants from (during year)
4	Aggregate value at end of year ........

Did the organization inform all donors and donor advisors in writing that the assets held in donor advised funds are the organization’s property, subject to the organization’s exclusive legal control? ............

Yes No

Did the organization inform all grantees, donors, and donor advisors in writing that grant funds can be used only for charitable purposes and not for the benefit of the donor or donor advisor, or for any other purpose conferring impermissible private benefit? ...................................

Yes No

Part II

Conservation Easements. Complete if the organization answered "Yes" on Form 990, Part IV, line 7.

Purpose(s) of conservation easements held by the organization (check all that apply).

Preservation of land for public use (e.g., recreation or education) Preservation of an historically important land area

Protection of natural habitat Preservation of a certified historic structure

Preservation of open space

Complete lines 2a through 2d if the organization held a qualified conservation contribution in the form of a conservation easement on the last day of the tax year.


a	Total number of conservation easements ......................	2a
b	Total acreage restricted by conservation easements ....................	2b
c	Number of conservation easements on a certified historic structure included in (a) .....	2c
d	Number of conservation easements included in (c) acquired after 7/25/06, and not on a historic structure listed in the National Register ...	2d

Number of conservation easements modified, transferred, released, extinguished, or terminated by the organization during the
tax year SchDMd Bullet

Number of states where property subject to conservation easement is located SchDMd Bullet

Does the organization have a written policy regarding the periodic monitoring, inspection, handling of violations, and enforcement of the conservation easements it holds? ............

Yes No

Staff and volunteer hours devoted to monitoring, inspecting, handling of violations, and enforcing conservation easements during the year
SchDMd Bullet

Amount of expenses incurred in monitoring, inspecting, handling of violations, and enforcing conservation easements during the year
SchDMd Bullet

Does each conservation easement reported on line 2(d) above satisfy the requirements of section 170(h)(4)(B)(i) and section 170(h)(4)(B)(ii)? .............................

Yes No

In Part XIII, describe how the organization reports conservation easements in its revenue and expense statement, and
balance sheet, and include, if applicable, the text of the footnote to the organization’s financial statements that describes
the organization’s accounting for conservation easements.

Part III

Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets.
Complete if the organization answered "Yes" on Form 990, Part IV, line 8.

If the organization elected, as permitted under SFAS 116 (ASC 958), not to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide, in Part XIII, the text of the footnote to its financial statements that describes these items.

If the organization elected, as permitted under SFAS 116 (ASC 958), to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide the following amounts relating to these items:

(i)

Revenue included on Form 990, Part VIII, line 1 ......................... SchDMd Bullet

(ii)

Assets included in Form 990, Part X ............................... SchDMd Bullet

If the organization received or held works of art, historical treasures, or other similar assets for financial gain, provide the
following amounts required to be reported under SFAS 116 (ASC 958) relating to these items:

Revenue included on Form 990, Part VIII, line 1 .......................... SchDMd Bullet

Assets included in Form 990, Part X ............................... SchDMd Bullet

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 52283D

Schedule D (Form 990) 2018

Page 2

Part III

Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets (continued)

Using the organization’s acquisition, accession, and other records, check any of the following that are a significant use of its collection items (check all that apply):

Public exhibition

Loan or exchange programs

Scholarly research

Other

Preservation for future generations

Provide a description of the organization’s collections and explain how they further the organization’s exempt purpose in
Part XIII.

During the year, did the organization solicit or receive donations of art, historical treasures or other similar
assets to be sold to raise funds rather than to be maintained as part of the organization’s collection?...

Yes No

Part IV

Escrow and Custodial Arrangements. Complete if the organization answered "Yes" on Form 990, Part IV, line 9, or reported an amount on Form 990, Part X, line 21.

Is the organization an agent, trustee, custodian or other intermediary for contributions or other assets not
included on Form 990, Part X? ....................................

Yes No


b	If "Yes," explain the arrangement in Part XIII and complete the following table:		Amount
c	Beginning balance .............................	1c
d	Additions during the year ............................	1d
e	Distributions during the year ..........................	1e
f	Ending balance ................................	1f

Did the organization include an amount on Form 990, Part X, line 21, for escrow or custodial account liability? ...

Yes No

If "Yes," explain the arrangement in Part XIII. Check here if the explanation has been provided in Part XIII ....

Part V

Endowment Funds. Complete if the organization answered "Yes" on Form 990, Part IV, line 10.

		(a)Current year	(b)Prior year	(c)Two years back	(d)Three years back	(e)Four years back

1a	Beginning of year balance ....	6,838,821	6,732,965	6,264,149	6,403,208	6,418,767
b	Contributions ...	1,480	6,019	291,302	1,700	2,340
c	Net investment earnings, gains, and losses	93,478	423,554	654,392	-65,917	312,633
d	Grants or scholarships ...
e	Other expenditures for facilities and programs ...	125,350	323,717	476,878	74,842	330,532
f	Administrative expenses ....
g	End of year balance ......	6,808,429	6,838,821	6,732,965	6,264,149	6,403,208

Provide the estimated percentage of the current year end balance (line 1g, column (a)) held as:

Board designated or quasi-endowment SchDMd Bullet

7.350 %

Permanent endowment SchDMd Bullet

74.780 %

Temporarily restricted endowment SchDMd Bullet

17.870 %

The percentages on lines 2a, 2b, and 2c should equal 100%.

Are there endowment funds not in the possession of the organization that are held and administered for the
organization by:

Yes

(i) unrelated organizations .................

3a(i)

(ii) related organizations .................

3a(ii)

If "Yes" on 3a(ii), are the related organizations listed as required on Schedule R? .........

Describe in Part XIII the intended uses of the organization's endowment funds.

Part VI

Land, Buildings, and Equipment.
Complete if the organization answered "Yes" on Form 990, Part IV, line 11a. See Form 990, Part X, line 10.

Description of property		(a) Cost or other basis (investment)	(b) Cost or other basis (other)	(c) Accumulated depreciation	(d) Book value

1a	Land .....
b	Buildings ....
c	Leasehold improvements
d	Equipment ....	83,984	72,586	11,398
e	Other .....
Total. Add lines 1a through 1e. (Column (d) must equal Form 990, Part X, column (B), line 10(c).)..				11,398

Schedule D (Form 990) 2018

Page 3

Part VII

InvestmentsOther Securities. Complete if the organization answered "Yes" on Form 990, Part IV, line 11b. See Form 990, Part X, line 12.

(a) Description of security or category (including name of security)	(b) Book value	(c) Method of valuation: Cost or end-of-year market value
(1) Financial derivatives.........
(2) Closely-held equity interests........
(3)Other
(A)
(B)
(C)
(D)
(E)
(F)
(G)
(H)
Total. (Column (b) must equal Form 990, Part X, col. (B) line 12.)

Part VIII

InvestmentsProgram Related. Complete if the organization answered 'Yes' on Form 990, Part IV, line 11c. See Form 990, Part X, line 13.

(a) Description of investment	(b) Book value	(c) Method of valuation: Cost or end-of-year market value

(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 13.)

Part IX

Other Assets. Complete if the organization answered 'Yes' on Form 990, Part IV, line 11d. See Form 990, Part X, line 15.

(a) Description				(b) Book value

(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 15.)...........

Part X

Other Liabilities. Complete if the organization answered 'Yes' on Form 990, Part IV, line 11e or 11f. See Form 990, Part X, line 25.

1.(a) Description of liability	(b) Book value
(1) Federal income taxes
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
Total. (Column (b) must equal Form 990, Part X, col.(B) line 25.)
2. Liability for uncertain tax positions. In Part XIII, provide the text of the footnote to the organization's financial statements that reports the organization's liability for uncertain tax positions under FIN 48 (ASC 740). Check here if the text of the footnote has been provided in Part XIII

Schedule D (Form 990) 2018

Page 4

Part XI Reconciliation of Revenue per Audited Financial Statements With Revenue per Return Complete if the organization answered 'Yes' on Form 990, Part IV, line 12a.
1	Total revenue, gains, and other support per audited financial statements .......			1	2,693,427
2	Amounts included on line 1 but not on Form 990, Part VIII, line 12:
a	Net unrealized gains (losses) on investments ....	2a	-343,754
b	Donated services and use of facilities .........	2b	272,713
c	Recoveries of prior year grants ...........	2c
d	Other (Describe in Part XIII.) ............	2d
e	Add lines 2a through 2d .....................			2e	-71,041
3	Subtract line 2e from line 1..................			3	2,764,468
4	Amounts included on Form 990, Part VIII, line 12, but not on line 1:
a	Investment expenses not included on Form 990, Part VIII, line 7b .	4a
b	Other (Describe in Part XIII.) ...........	4b
c	Add lines 4a and 4b....................			4c	0
5	Total revenue. Add lines 3 and 4c. (This must equal Form 990, Part I, line 12.) ......			5	2,764,468

Part XII Reconciliation of Expenses per Audited Financial Statements With Expenses per Return. Complete if the organization answered 'Yes' on Form 990, Part IV, line 12a.
1	Total expenses and losses per audited financial statements ...........			1	2,866,034
2	Amounts included on line 1 but not on Form 990, Part IX, line 25:
a	Donated services and use of facilities .........	2a	272,713
b	Prior year adjustments ............	2b
c	Other losses ................	2c
d	Other (Describe in Part XIII.) ............	2d
e	Add lines 2a through 2d....................			2e	272,713
3	Subtract line 2e from line 1...................			3	2,593,321
4	Amounts included on Form 990, Part IX, line 25, but not on line 1:
a	Investment expenses not included on Form 990, Part VIII, line 7b ..	4a
b	Other (Describe in Part XIII.) ............	4b
c	Add lines 4a and 4b.....................			4c	0
5	Total expenses. Add lines 3 and 4c. (This must equal Form 990, Part I, line 18.) ......			5	2,593,321

Part XIII

Supplemental Information

Provide the descriptions required for Part II, lines 3, 5, and 9; Part III, lines 1a and 4; Part lV, lines 1b and 2b; Part V, line 4; Part X, line 2; Part XI, lines 2d and 4b; and Part XII, lines 2d and 4b. Also complete this part to provide any additional information.

Return Reference	Explanation
PART V, LINE 4:	THE FOUNDATION'S ENDOWMENT PRIMARILY CONSISTS OF CONTRIBUTIONS TO THE JOSEPH A. ODDIS ENDOWMENT CAMPAIGN, THE PURPOSE OF WHICH IS TO RAISE FUNDS FOR PROGRAMS THAT IMPROVE PHARMACY PRACTICE AND THE SAFE AND EFFECTIVE USE OF MEDICATIONS.

Schedule D (Form 990) 2018

Additional Data

Software ID:
Software Version:

- TIN:

Note: To capture the full content of this document, please select landscape mode (11" x 8.5") when printing.

Schedule I
(Form 990)

Department of the Treasury
Internal Revenue Service

Grants and Other Assistance to Organizations,
Governments and Individuals in the United States

Complete if the organization answered "Yes," on Form 990, Part IV, line 21 or 22.
lBullet

Attach to Form 990.
lBullet

Go to www.irs.gov/Form990 for the latest information.

OMB No. 1545-0047

2018

Open to Public
Inspection

Name of the organization
AMERICAN SOCIETY OF HEALTH-SYSTEM
PHARMACISTS RESEARCH AND EDUCATION FDTN

Employer identification number
23-7033369

Part I

General Information on Grants and Assistance

Does the organization maintain records to substantiate the amount of the grants or assistance, the grantees' eligibility for the grants or assistance, and
the selection criteria used to award the grants or assistance? ........................

Yes No

Describe in Part IV the organization's procedures for monitoring the use of grant funds in the United States.

Part II

Grants and Other Assistance to Domestic Organizations and Domestic Governments. Complete if the organization answered "Yes" on Form 990, Part IV, line 21, for any recipient

that received more than $5,000. Part II can be duplicated if additional space is needed.

(a) Name and address of organization or government	(b) EIN	(c) IRC section (if applicable)	(d) Amount of cash grant	(h) Purpose of grant or assistance
(1) AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION ONE CHURCH STREET ROCKVILLE,MD20850	53-0214882	501(C)3	7,500	2018 SPONSORSHIP
(2) AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISITS 4500 EAST-WEST HIGHWAY BETHESDA,MD20814	52-0807628	501(C)6	30,133	CLINICAL SKILLS COMPETITION
(3) ASCENSION VIA CHRISTI HEALTH INC 8200 E THORN WICHITA,KS67226	48-1172107	501(C)3	25,000	RESIDENCY EXPANSION GRANT
(4) BAPTIST MEMORIAL HOSPITAL 350 N HUMPHREYS BLVD MEMPHIS,TN38120	62-0123940	501(C)3	29,663	AWARD FOR EXCELLENCE
(5) CHILDREN'S HOSPITAL COLORADO 13123 EAST 16TH AVENUE BOX 015 AURORA,CO80045	84-0166760	501(C)3	25,000	RESIDENCY EXPANSION GRANT
(6) H LEE MOFFITT CNCER CENTER AND RESEARCH INSTITUTE INC 12902 MAGNOLIA DRIVE TAMPA,FL33612	59-2451713	501(C)3	49,436	PHARMACY PRACTICE GRANT
(7) HARRIS COUNTRY HOSPITAL DISTRICT 2325 HOLLY HALL PO BOX 66769 HOUSTON,TX77266	74-1536936	STATE AGENCY	25,000	RESIDENCY EXPANSION GRANT
(8) MARY HITCHCOCK MEMORIAL HOSPITAL ONE MEDICAL CENTER DRIVE LEBANON,NH03756	02-0222140	501(C)3	25,000	RESIDENCY EXPANSION GRANT
(9) NEBRASKA MEDICAL CENTER THE 987455 NEBRASKA MEDICAL CENTER OMAHA,NE68198	91-1858433	501(C)3	25,000	RESIDENCY EXPANSION GRANT
(10) STRAUB MEDICAL CENTER 888 SOUTH KING STREET HONOLULU,HI96813	91-2151670	501(C)3	10,000	AWARD FOR EXCELLENCE
(11) THE RESEARCH FOUNDATION FOR SUNY 35 STATE STREET ALBANY,NY12207	14-1368361	501(C)3	13,200	NEW INVESTIGATOR RESEARCH GRANT
(12) UNIVERSITY OF COLORADO DENVER 1800 GRANT STREET SUITE 600 DENVER,CO80203	84-6000555	STATE AGENCY	25,497	PHARMACY PRATICE MODEL GRANT
(13) UNIVERSITY OF FLORIDA FOUNDATION INC 1938 WEST UNIVERSITY AVE PO BOX 14425 GAINSVILLE,FL32604	59-0974739	501(C)3	10,000	AWARD FOR EXCELLENCE
(14) UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 109 KINKEAD HALL LEXINGTON,KY40506	61-6033693	501(C)3	62,336	NEW INVESTIGATOR GRANT, PHARMACY PRACTICE GRANT
(15) UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 103 SOUTH BUILDING CAMPUS BOX 9100 CHAPEL HILL,NC27599	56-6001393	STATE AGENCY	10,000	NEW PRACTITIONER GRANT; RESIDENCY RESEARCH GRANT
(16) UNIVERSITY OF TOLEDO 2801 WEST BRANCROFT STREET TOLEDO,OH43606	34-6401483	STATE AGENCY	6,800	NEW INVESTIGATOR GRANT
(17) UNIVERSITY OF UTAH 201 S PRESIDENTS CIRCLE ROOM 411 SALT LAKE CITY,UT84112	87-6000525	501(C)3	6,800	NEW INVESTIGATOR GRANT

Enter total number of section 501(c)(3) and government organizations listed in the line 1 table ................. Bullet Image

Enter total number of other organizations listed in the line 1 table ........................ . Bullet Image

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50055P

Schedule I (Form 990) 2018

Page 2

Part III

Grants and Other Assistance to Domestic Individuals. Complete if the organization answered "Yes" on Form 990, Part IV, line 22.
Part III can be duplicated if additional space is needed.

(a) Type of grant or assistance	(b) Number of recipients	(c) Amount of cash grant	(d) Amount of noncash assistance	(e) Method of valuation (book, FMV, appraisal, other)	(f) Description of noncash assistance

(1) LITERATURE AWARD	5	18,500
(2) STUDENT LEADERSHIP AWARDS	10	20,000
(2)
(3)
(4)
(5)
(6)
(7)

Part IV

Supplemental Information. Provide the information required in Part I, line 2; Part III, column (b); and any other additional information.

Return Reference	Explanation
PART I, LINE 2:	THE ASHP FOUNDATION HAS A DETAILED REPORTING REQUIREMENT FOR ALL GRANTS AWARDED WHICH INCLUDES REPORTING PROGRESS AT 6-MONTH INTERVALS. ANY UNUSED GRANT FUNDS MUST BE RETURNED. THE ASHP FOUNDATION HAS A GOOD TRACK RECORD OF ENSURING STUDY COMPLETION AND PUBLICATION OF STUDY RESULTS.

Schedule I (Form 990) 2018

Additional Data

Software ID:
Software Version:

- TIN:

Schedule J
(Form 990)

Department of the Treasury
Internal Revenue Service

Compensation Information

For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
SchJMediumBullet

Complete if the organization answered "Yes" on Form 990, Part IV, line 23.
SchJMediumBullet

Attach to Form 990.
SchJMediumBullet

Go to www.irs.gov/Form990 for instructions and the latest information.

OMB No. 1545-0047

2018

Open to Public Inspection

Name of the organization

AMERICAN SOCIETY OF HEALTH-SYSTEM
PHARMACISTS RESEARCH AND EDUCATION FDTN

Employer identification number

23-7033369

Part I

Questions Regarding Compensation

Yes

Check the appropiate box(es) if the organization provided any of the following to or for a person listed on Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.

First-class or charter travel Housing allowance or residence for personal use

Travel for companions Payments for business use of personal residence

Tax idemnification and gross-up payments Health or social club dues or initiation fees

Discretionary spending account Personal services (e.g., maid, chauffeur, chef)

If any of the boxes in line 1a are checked, did the organization follow a written policy regarding payment or reimbursement or provision of all of the expenses described above? If "No," complete Part III to explain .........

Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all
directors, trustees, officers, including the CEO/Executive Director, regarding the items checked in line 1a? ..

Indicate which, if any, of the following the filing organization used to establish the compensation of the
organization's CEO/Executive Director. Check all that apply. Do not check any boxes for methods
used by a related organization to establish compensation of the CEO/Executive Director, but explain in Part III.

Compensation committee Written employment contract

Independent compensation consultant Compensation survey or study

Form 990 of other organizations Approval by the board or compensation committee

During the year, did any person listed on Form 990, Part VII, Section A, line 1a, with respect to the filing organization or a related organization:

Receive a severance payment or change-of-control payment? .............

Participate in, or receive payment from, a supplemental nonqualified retirement plan? .........

Participate in, or receive payment from, an equity-based compensation arrangement? .........

If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.

Only 501(c)(3), 501(c)(4), and 501(c)(29) organizations must complete lines 5-9.

For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:

The organization? ....................

Any related organization? .......................

If "Yes," on line 5a or 5b, describe in Part III.

For persons listed on Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:

The organization? ..................

Yes

Any related organization? ......................

Yes

If "Yes," on line 6a or 6b, describe in Part III.

For persons listed on Form 990, Part VII, Section A, line 1a, did the organization provide any nonfixed
payments not described in lines 5 and 6? If "Yes," describe in Part III ............

Yes

Were any amounts reported on Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regulations section 53.4958-4(a)(3)? If "Yes," describe
in Part III ..........................

If "Yes" on line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)? .........................

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50053T

Schedule J (Form 990) 2018

Page 2

Part II

Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees. Use duplicate copies if additional space is needed.

For each individual whose compensation must be reported on Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions, on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.
Note. The sum of columns (B)(i)-(iii) for each listed individual must equal the total amount of Form 990, Part VII, Section A, line 1a, applicable column (D) and (E) amounts for that individual.

(A) Name and Title		(B) Breakdown of W-2 and/or 1099-MISC compensation			(C) Retirement and other deferred compensation	(D) Nontaxable benefits	(E) Total of columns (B)(i)-(D)	(F) Compensation in column (B) reported as deferred on prior Form 990
(A) Name and Title		(i) Base compensation	(ii) Bonus & incentive compensation	(iii) Other reportable compensation	(C) Retirement and other deferred compensation	(D) Nontaxable benefits	(E) Total of columns (B)(i)-(D)
1PAUL W ABRAMOWITZ PRESIDENT/ASHP CEO	(i) (ii)	0 ------------- 731,713	0 ------------- 109,500	0 ------------- 28,744	0 ------------- 27,200	0 ------------- 31,544	0 ------------- 928,701	0 ------------- 0
2STEVEN A RUBLOFF SECY/ASHP REF CEO	(i) (ii)	291,153 ------------- 0	10,000 ------------- 0	1,139 ------------- 0	0 ------------- 0	36,664 ------------- 0	338,956 ------------- 0	0 ------------- 0
3BARBARA NUSSBAUM VICE PRESIDENT	(i) (ii)	166,000 ------------- 0	5,625 ------------- 0	875 ------------- 0	18,014 ------------- 0	40,552 ------------- 0	231,066 ------------- 0	0 ------------- 0
4BETHANY COULTER DIR. OF STRATEGIC COMM (THRU 12/18)	(i) (ii)	124,498 ------------- 0	4,274 ------------- 0	5,002 ------------- 0	13,400 ------------- 0	13,859 ------------- 0	161,033 ------------- 0	0 ------------- 0
5STEPHEN J ALLEN FORMER SECY/ASHP REF CEO (THRU 2/18)	(i) (ii)	29,638 ------------- 0	0 ------------- 0	38,300 ------------- 0	17,550 ------------- 0	2,213 ------------- 0	87,701 ------------- 0	0 ------------- 0

Schedule J (Form 990) 2018

Page 3

Part III

Supplemental Information

Provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4a, 4b, 4c, 5a, 5b, 6a, 6b, 7, and 8, and for Part II. Also complete this part for any additional information.

Return Reference	Explanation
PART I, LINE 6	PAUL ABRAMOWITZ, PRESIDENT/ASHP CEO, AND STEVEN RUBLOFF SECRETARY/ASHP REF CEO, RECEIVE A BONUS BASED ON THE ACHIEVEMENT OF SPECIFIC FINANCIAL OUTCOMES FOR THEIR RESPECTIVE ORGANIZATIONS.
PART I, LINE 7	ALL ASHP-REF EMPLOYEES ARE ELIGIBLE FOR AN ANNUAL PERFORMANCE INCENTIVE PROGRAM IN ACCORDANCE WITH POLICY, AT THE DISCRETION OF THE BOARD OF DIRECTORS, BASED ON MUTUALLY AGREED UPON PREDETERMINED OBJECTIVES.

Schedule J (Form 990) 2018

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE M
(Form 990)

Department of the Treasury

Internal Revenue Service

Noncash Contributions

Complete if the organizations answered "Yes" on Form 990, Part IV, lines 29 or 30.
Right pointing arrow large image

Attach to Form 990.
Right pointing arrow large image

Go to www.irs.gov/Form990 for the latest information.

OMB No. 1545-0047

2018

Open to Public Inspection

Name of the organization

AMERICAN SOCIETY OF HEALTH-SYSTEM
PHARMACISTS RESEARCH AND EDUCATION FDTN

Employer identification number

23-7033369

Part I

Types of Property

	(a) Check if applicable	(b) Number of contributions or items contributed	(c) Noncash contribution amounts reported on Form 990, Part VIII, line 1g	(d) Method of determining noncash contribution amounts
1 Art—Works of art ....
2 Art—Historical treasures .
3 Art—Fractional interests ..
4 Books and publications ..
5 Clothing and household goods .......
6 Cars and other vehicles ..
7 Boats and planes ....
8 Intellectual property ...
9 Securities—Publicly traded .	X	1	100,700	CASH SALES VALUE
10 Securities—Closely held stock .
11 Securities—Partnership, LLC, or trust interests ....
12 Securities—Miscellaneous ..
13 Qualified conservation contribution—Historic structures .....
14 Qualified conservation contribution—Other ...
15 Real estate—Residential .
16 Real estate—Commercial ..
17 Real estate—Other ...
18 Collectibles .....
19 Food inventory ...
20 Drugs and medical supplies .
21 Taxidermy ......
22 Historical artifacts ....
23 Scientific specimens ..
24 Archeological artifacts ...
25 Other ( )
26 Other ( )
27 Other ( )
28 Other ( )

Number of Forms 8283 received by the organization during the tax year for contributions
for which the organization completed Form 8283, Part IV, Donee Acknowledgement

Yes

30a

During the year, did the organization receive by contribution any property reported in Part I, lines 1 through 28, that it must hold for at least three years from the date of the initial contribution, and which is not required to be used for exempt purposes for the entire holding period? ...................

30a

If "Yes," describe the arrangement in Part II.

Does the organization have a gift acceptance policy that requires the review of any nonstandard contributions?

Yes

32a

Does the organization hire or use third parties or related organizations to solicit, process, or sell noncash

contributions? ..........................

32a

If "Yes," describe in Part II.

If the organization did not report an amount in column (c) for a type of property for which column (a) is checked,

describe in Part II.

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 51227J

Schedule M (Form 990) (2018)

Page 2

Part II

Supplemental Information. Provide the information required by Part I, lines 30b, 32b, and 33, and whether the organization is reporting in Part I, column (b), the number of contributions, the number of items received, or a combination of both. Also complete this part for any additional information.

Return Reference	Explanation
PART I, COLUMN (B):	REPRESENTS THE TOTAL NUMBER OF CONTRIBUTIONS CONTRIBUTED AND NOT NECESSARILY THE TOTAL NUMBER OF ITEMS CONTRIBUTED.

Schedule M (Form 990) (2018)

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE O
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service

Supplemental Information to Form 990 or 990-EZ

Complete to provide information for responses to specific questions on
Form 990 or 990-EZ or to provide any additional information.
MediumBullet

Attach to Form 990 or 990-EZ.
MediumBullet

Go to www.irs.gov/Form990 for the latest information.

OMB No. 1545-0047

2018

Open to Public
Inspection

Name of the organization

AMERICAN SOCIETY OF HEALTH-SYSTEM
PHARMACISTS RESEARCH AND EDUCATION FDTN

Employer identification number

23-7033369

Return Reference	Explanation
FORM 990, PART III, LINE 2	THE ASHP FOUNDATION UPDATED THE STRATEGIC PRIORITIES TO BE: 1. INNOVATIVE RESEARCH 2. EXCELLENCE IN PHARMACY PRACTICE & LEADERSHIP DEVELOPMENT.
PHARMACY RESIDENCY EXPANSION GRANT	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
FORM 990, PART VI, SECTION A, LINE 7A	THREE MANDATORY MEMBERS OF THE FOUNDATION'S BOARD OF DIRECTORS ARE: THE IMMEDIATE PAST PRESIDENT, EXECUTIVE VICE PRESIDENT, AND TREASURER OF THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS, A RELATED 501(C)(6) MEMBERSHIP ORGANIZATION. THE AFOREMENTIONED TREASURER AND EXECUTIVE VICE PRESIDENT SHALL SERVE, RESPECTIVELY, AS THE TREASURER AND PRESIDENT OF THE FOUNDATION, AND THE IMMEDIATE PAST PRESIDENT SHALL SERVE AS A DIRECTOR OF THE FOUNDATION. THE BOARD OF DIRECTORS OF THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS MAY ALSO APPOINT ONE OR MORE MEMBERS OF THE PUBLIC TO SERVE AS MEMBERS OF THE FOUNDATION'S BOARD.
FORM 990, PART VI, SECTION A, LINE 8B	THERE ARE NO COMMITTEES THAT HAVE THE AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY.
FORM 990, PART VI, SECTION B, LINE 11B	THE FORM 990 IS REVIEWED BY THE CHIEF OPERATIONS AND FINANCIAL OFFICERS AND BY THE BOARD BEFORE IT IS FILED. A COPY OF THE FORM 990 IS PROVIDED TO EACH MEMBER OF THE BOARD OF DIRECTORS.
FORM 990, PART VI, SECTION B, LINE 12C	THE CONFLICT OF INTEREST POLICY WILL BE REVIEWED ANNUALLY AT THE SPRING OR FALL MEETING
FORM 990, PART VI, SECTION B, LINE 15A	CEO, EXECUTIVE DIRECTOR OR TOP MANAGEMENT: A "CEO EVALUATION SUBCOMMITTEE" IS APPOINTED BY THE BOARD AND MEETS SEVERAL TIMES ON AN ANNUAL BASIS. THIS SUBCOMMITTEE IS RESPONSIBLE FOR EVALUATING CEO PERFORMANCE ANNUALLY AND NEGOTIATING A CONTRACT THAT CUSTOMARILY SPANS A 3-YEAR PERIOD. THE TREASURER CHAIRS THE SUBCOMMITTEE DURING THE CONTRACT RENEGOTIATION YEAR AND THE BOARD CHAIR LEADS THE SUBCOMMITTEE DURING NON-CONTRACT YEAR ANNUAL REVIEWS. ALL SUBCOMMITTEE ACTIONS ARE REVIEWED BY THE FULL BOARD PRIOR TO TAKING ANY ACTIONS. ONE FULL YEAR PRIOR TO THE COMPLETION OF A CONTRACT CYCLE, THE SUBCOMMITTEE MAKES A REFLECTIVE REVIEW OF PERFORMANCE DURING THE CONTRACT PERIOD. ADDITIONALLY, A CEO SELF-ASSESSMENT IS COMPLETED AND REVIEWED BY THE SUBCOMMITTEE. THE REFLECTIVE PERFORMANCE REVIEW AND SELF-ASSESSMENT IS CONSIDERED BY THE BOARD AND A DECISION IS MADE AS TO WHETHER THE BOARD DESIRES TO RENEGOTIATE A NEW CONTRACT WITH THE EXISTING CEO OR SEEK A REPLACEMENT. IF A REPLACEMENT IS DESIRED, THEN A SEARCH COMMITTEE IS APPOINTED. IF CONTRACT RENEGOTIATION WITH THE CURRENT CEO IS DESIRED, THE CEO EVALUATION COMMITTEE LEADS CONTRACT RENEGOTIATIONS UNDER THE LEADERSHIP OF THE TREASURER. A CONTRACT FOR THE BOARD'S CONSIDERATION IS ESTABLISHED IN WRITING WITH ALL PROVISIONS OUTLINED, INCLUDING COMPENSATION AND BENEFITS. TO DETERMINE PROPOSED COMPENSATION THE SUBCOMMITTEE REVIEWS 1) NATIONAL SURVEY DATA FOR THE CEO POSITION; 2) THE AMERICAN SOCIETY OF ASSOCIATION EXECUTIVE (ASAE) COMPENSATION DATA FOR EXECUTIVES IS REVIEWED FOCUSING ON SIMILAR/COMPETITIVE HEALTHCARE ORGANIZATIONS IN THE MID-ATLANTIC REGION; AND 3) GUIDESTAR'S DATABASE IS REFERENCED TO IDENTIFY CEO COMPENSATION IN COMPETITIVE ORGANIZATION'S 990 FILINGS. ULTIMATELY, A NEW CONTRACT IS PRESENTED TO THE BOARD FOR APPROVAL THAT OUTLINES COMPENSATION AND PERFORMANCE EXPECTATIONS. IN NON-CONTRACT RENEWAL YEARS, THE SUBCOMMITTEE COMPLETES A DRAFT ANNUAL PERFORMANCE REVIEW FOR THE BOARD'S CONSIDERATION PRIOR TO CONDUCTING THE ANNUAL PERFORMANCE REVIEW ALONG WITH A SET OF CEO PERFORMANCE OBJECTIVES FOR THE UPCOMING YEAR AND A CEO SELF-ASSESSMENT SUMMARY. IN ALL CASES CEO PERFORMANCE IS MEASURED AGAINST BOARD-APPROVED ANNUAL PERFORMANCE OBJECTIVES. OTHER OFFICERS OR KEY EMPLOYEES: THE CEO DETERMINES COMPENSATION FOR KEY EMPLOYEES RELYING HEAVILY UPON THE GUIDANCE OF THE HUMAN RESOURCES DEPARTMENT OF ASHP. ASAE SURVEY DATA IS REVIEWED WHEN COMPARABLE POSITIONS EXIST FOR THE KEY EMPLOYEE POSITION (E.G. DIRECTOR OF COMMUNICATIONS). THE HUMAN RESOURCES DEPARTMENT UTILIZES ADDITIONAL SALARY SURVEY DATABASES TO COMPARE SALARIES. FOR POSITIONS WHERE A PHARMACIST IS A JOB REQUIREMENT, PHARMACIST POSITIONS IN HOSPITALS AND HEALTH-SYSTEMS THAT WOULD BE LIKELY CANDIDATE POOLS ARE QUERIED IN THE SALARY SURVEY DATABASES. ADDITIONALLY, THE HR DEPARTMENT CAN PROVIDE COMPARATIVE DATA FOR PHARMACIST POSITIONS AT ASHP.
FORM 990, PART VI, SECTION C, LINE 19	THE FOUNDATION'S FINANCIAL STATEMENTS, GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST.
FORM 990, PART IX, LINE 11G	CONTRACT SERVICES: PROGRAM SERVICE EXPENSES 378,992. MANAGEMENT AND GENERAL EXPENSES 71,884. FUNDRAISING EXPENSES 40,203. TOTAL EXPENSES 491,079.

For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.

Cat. No. 51056K

Schedule O (Form 990 or 990-EZ) 2018

Additional Data

Software ID:
Software Version:

- TIN:

SCHEDULE R
(Form 990)

Department of the Treasury
Internal Revenue Service

Related Organizations and Unrelated Partnerships

Complete if the organization answered "Yes" on Form 990, Part IV, line 33, 34, 35b, 36, or 37.
MediumBullet

Attach to Form 990.
MediumBullet

Go to www.irs.gov/Form990 for instructions and the latest information.

OMB No. 1545-0047

2018

Open to Public Inspection

Name of the organization

AMERICAN SOCIETY OF HEALTH-SYSTEM
PHARMACISTS RESEARCH AND EDUCATION FDTN

Employer identification number

23-7033369

Part I

Identification of Disregarded Entities Complete if the organization answered "Yes" on Form 990, Part IV, line 33.

(a) Name, address, and EIN (if applicable) of disregarded entity	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Total income	(e) End-of-year assets	(f) Direct controlling entity

Part II

Identification of Related Tax-Exempt Organizations Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related tax-exempt organizations during the tax year.

(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Exempt Code section	(e) Public charity status (if section 501(c)(3))	(f) Direct controlling entity	(g) Section 512(b)(13) controlled entity?
(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Exempt Code section	(e) Public charity status (if section 501(c)(3))	(f) Direct controlling entity	Yes	No
(1)AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS (ASHP) 4500 EAST-WEST HIGHWAY SUITE 900 BETHESDA,MD20814 52-0807628	TO ADVANCE PUBLIC HEALTH BY SUPPORTING THE PHARMACY PROFESSION	MD	501(C)(6)		N/A		No
(2)7272 WISCONSIN BUILDING CORPORATION 4500 EAST-WEST HIGHWAY SUITE 900 BETHESDA,MD20814 52-1760057	TITLE HOLDING COMPANY	MD	501(C)(2)		ASHP		No

For Paperwork Reduction Act Notice, see the Instructions for Form 990.

Cat. No. 50135Y

Schedule R (Form 990) 2018

Page 2

Part III

Identification of Related Organizations Taxable as a Partnership Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related organizations treated as a partnership during the tax year.

(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Direct controlling entity	(f) Share of total income	(g) Share of end-of-year assets	(h) Disproprtionate allocations?		(i) Code V-UBI amount in box 20 of Schedule K-1 (Form 1065)	(j) General or managing partner?
(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Direct controlling entity	(f) Share of total income	(g) Share of end-of-year assets	Yes	No	(i) Code V-UBI amount in box 20 of Schedule K-1 (Form 1065)	Yes	No

Part IV

Identification of Related Organizations Taxable as a Corporation or Trust Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related organizations treated as a corporation or trust during the tax year.

(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Direct controlling entity	(e) Type of entity (C corp, S corp, or trust)	(f) Share of total income	(g) Share of end-of-year assets	(i) Section 512(b)(13) controlled entity?
(a) Name, address, and EIN of related organization	(b) Primary activity	(c) Legal domicile (state or foreign country)	(d) Direct controlling entity	(e) Type of entity (C corp, S corp, or trust)	(f) Share of total income	(g) Share of end-of-year assets	Yes	No

Schedule R (Form 990) 2018

Page 3

Part V

Transactions With Related Organizations Complete if the organization answered "Yes" on Form 990, Part IV, line 34, 35b, or 36.

Note. Complete line 1 if any entity is listed in Parts II, III, or IV of this schedule.

Yes

1 During the tax year, did the orgranization engage in any of the following transactions with one or more related organizations listed in Parts II-IV?

a Receipt of (i) interest, (ii) annuities, (iii) royalties, or (iv) rent from a controlled entity .....................

b Gift, grant, or capital contribution to related organization(s) ............................

Yes

c Gift, grant, or capital contribution from related organization(s) ............................

Yes

d Loans or loan guarantees to or for related organization(s) ............................

e Loans or loan guarantees by related organization(s) ............................

f Dividends from related organization(s) ............................

g Sale of assets to related organization(s) ............................

h Purchase of assets from related organization(s) ............................

i Exchange of assets with related organization(s) ............................

j Lease of facilities, equipment, or other assets to related organization(s) .......................

k Lease of facilities, equipment, or other assets from related organization(s) ......................

l Performance of services or membership or fundraising solicitations for related organization(s) .....................

m Performance of services or membership or fundraising solicitations by related organization(s) .................

n Sharing of facilities, equipment, mailing lists, or other assets with related organization(s) ...................

Yes

o Sharing of paid employees with related organization(s) ............................

Yes

p Reimbursement paid to related organization(s) for expenses ............................

Yes

q Reimbursement paid by related organization(s) for expenses ............................

r Other transfer of cash or property to related organization(s) ............................

s Other transfer of cash or property from related organization(s) ............................

Yes

If the answer to any of the above is "Yes," see the instructions for information on who must complete this line, including covered relationships and transaction thresholds.

(a) Name of related organization	(b) Transaction type (a-s)	(c) Amount involved	(d) Method of determining amount involved
(1) AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS	C	365,757	CASH
(2) AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS	N	875,309	RECORDED EXPENSES
(3) AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS	O	238,693	FAIR VALUE
(4) AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS	P	1,561,393	RECORDED EXPENSES
(5) AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS	S	686,084	CASH

Schedule R (Form 990) 2018

Page 4

Part VI

Unrelated Organizations Taxable as a Partnership Complete if the organization answered "Yes" on Form 990, Part IV, line 37.

Provide the following information for each entity taxed as a partnership through which the organization conducted more than five percent of its activities (measured by total assets or gross revenue) that was not a related organization. See instructions regarding exclusion for certain investment partnerships.

(a) Name, address, and EIN of entity	(b) Primary activity	(c) Legal domicile (state or foreign country)	(e) Are all partners section 501(c)(3) organizations?		(f) Share of total income	(g) Share of end-of-year assets	(h) Disproprtionate allocations?		(i) Code V-UBI amount in box 20 of Schedule K-1 (Form 1065)	(j) General or managing partner?
(a) Name, address, and EIN of entity	(b) Primary activity	(c) Legal domicile (state or foreign country)	Yes	No	(f) Share of total income	(g) Share of end-of-year assets	Yes	No	(i) Code V-UBI amount in box 20 of Schedule K-1 (Form 1065)	Yes	No

Schedule R (Form 990) 2018

Page 5

Part VII

Supplemental Information

Provide additional information for responses to questions on Schedule R (see instructions).

Return Reference	Explanation

Schedule R (Form 990) 2018

Additional Data

Software ID:
Software Version:

1	Briefly describe the organization’s mission or most significant activities: THE MISSION OF THE ASHP FOUNDATION IS TO SUPPORT ASHP BY ADVANCING THE PROFESSIONAL PRACTICE OF PHARMACISTS AND THE PHARMACY WORKFORCE BY FUNDING RESEARCH AND EDUCATION THAT IMPROVES HEALTH OUTCOMES THROUGH OPTIMAL, SAFE AND EFFECTIVE MEDICATION USE.
2	Check this box
3	Number of voting members of the governing body (Part VI, line 1a) ........	3	12
4	Number of independent voting members of the governing body (Part VI, line 1b) .....	4	8
5	Total number of individuals employed in calendar year 2018 (Part V, line 2a) ......	5	0
6	Total number of volunteers (estimate if necessary) .............	6	125
7a	Total unrelated business revenue from Part VIII, column (C), line 12 ........	7a	0
b	Net unrelated business taxable income from Form 990-T, line 34 .........	7b	0

		Prior Year	Current Year
8	Contributions and grants (Part VIII, line 1h) .........	2,088,349	1,768,602
9	Program service revenue (Part VIII, line 2g) .........	653,770	512,137
10	Investment income (Part VIII, column (A), lines 3, 4, and 7d ) ....	452,580	483,729
11	Other revenue (Part VIII, column (A), lines 5, 6d, 8c, 9c, 10c, and 11e)	0	0
12	Total revenue—add lines 8 through 11 (must equal Part VIII, column (A), line 12)	3,194,699	2,764,468
13	Grants and similar amounts paid (Part IX, column (A), lines 1–3 )...	965,609	476,870
14	Benefits paid to or for members (Part IX, column (A), line 4).....	0	0
15	Salaries, other compensation, employee benefits (Part IX, column (A), lines 5–10)	1,520,246	1,411,898
16a	Professional fundraising fees (Part IX, column (A), line 11e) .....	0	0
b	Total fundraising expenses (Part IX, column (D), line 25) 696,470
17	Other expenses (Part IX, column (A), lines 11a–11d, 11f–24e)....	693,146	704,553
18	Total expenses. Add lines 13–17 (must equal Part IX, column (A), line 25)	3,179,001	2,593,321
19	Revenue less expenses. Subtract line 18 from line 12.......	15,698	171,147
		Beginning of Current Year	End of Year
20	Total assets (Part X, line 16).............	10,165,674	10,276,086
21	Total liabilities (Part X, line 26).............	571,192	854,211
22	Net assets or fund balances. Subtract line 21 from line 20.....	9,594,482	9,421,875

Sign Here

	Signature of officer	Date

	Type or print name and title


4a	(Code: ) (Expenses $ 1,054,485 including grants of $ 253,528 ) (Revenue $ )
	EXCELLENCE IN PHARMACY PRACTICE & LEADERSHIP DEVELOPMENT: RECOGNIZE AND PROMOTE EFFORTS THAT FOSTER EXCELLENCE AND GROWTH OF HEALTH-SYSTEM PHARMACYASHP STUDENT LEADERSHIP AWARD THIS PROGRAM, FUNDED THROUGH THE WALTER JONES MEMORIAL PHARMACY STUDENT FUND, IS ADMINISTERED BY THE ASHP PHARMACY STUDENT FORUM IN COLLABORATION WITH THE ASHP FOUNDATION. TWELVE STUDENTS WHO DEMONSTRATE HIGH ACADEMIC ACHIEVEMENT, EXCEPTIONAL INTEREST IN HEALTH-SYSTEM PHARMACY PRACTICE, AND OUTSTANDING LEADERSHIP SKILLS WERE RECOGNIZED. RECIPIENTS WERE: CLASS OF 2019 - EMILY BUATOIS, PURDUE UNIVERSITY COLLEGE OF PHARMACY, LAFAYETTE, IN; GEANNETTE GREEN, UNIVERSITY OF TEXAS AT AUSTIN SCHOOL OF PHARMACY, AUSTIN, TX; LAUREN HAMMOND, SAMFORD UNIVERSITY MCWHORTER SCHOOL OF PHARMACY, HOMEWOOD, AL; DANIEL PONS, UNIVERSITY OF KANSAS SCHOOL OF PHARMACY, LAWRENCE, KS; NICHOLAS PUGLIESE, UNIVERSITY OF CONNECTICUT SCHOOL OF PHARMACY, MANSFIELD, CTCLASS OF 2020 - JUSTIN CULSHAW, UNIVERSITY OF RHODE ISLAND COLLEGE OF PHARMACY, SOUTH KINGSTOWN, RI; DAVID GIANG, UNIVERSITY OF TEXAS AT AUSTIN COLLEGE OF PHARMACY, AUSTIN, TX; HANNAH HECHT, UNIVERSITY OF WISCONSIN - MADISON SCHOOL OF PHARMACY, MADISON, WI; JENNY QUYNH THO NGUYEN, MCPHS UNIVERSITY SCHOOL OF PHARMACY BOSTON, BOSTON, MA; CASSANDRA SCHMITT, VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF PHARMACY, RICHMOND, VATHE AWARDEES RECEIVED A PLAQUE, A $2,000 AWARD AND AN ASHP DRUG INFORMATION LIBRARY. EACH AWARDEE SUBMITTED A PLAN TO RAISE STUDENT AWARENESS OF THE PRACTICE ADVANCEMENT INITIATIVE. AWARDEES WILL BE SURVEYED TO COLLECT INFORMATION ON IMPLEMENTATION AND OUTCOMES OF THEIR PLAN.AWARD FOR EXCELLENCE IN MEDICATION SAFETYA COLLABORATION BETWEEN THE CARDINAL HEALTH FOUNDATION AND ASHP FOUNDATION, THIS PROGRAM IS DESIGNED TO RECOGNIZE PHARMACIST-LED INTER-PROFESSIONAL TEAMS THAT MAKE SIGNIFICANT INSTITUTION-WIDE SYSTEM IMPROVEMENTS RELATING TO SAFE MEDICATION USE. THE 2018 RECIPIENT AND FINALIST ORGANIZATIONS WERE SELECTED USING A LETTER OF INTENT PROCESS UNDERTAKEN BY AN INDEPENDENT INTER-PROFESSIONAL PANEL OF EXPERTS IN THE FIELD OF MEDICATION SAFETY AND HEALTHCARE ADMINISTRATION. BAPTIST MEMORIAL HOSPITAL IN MEMPHIS, TN RECEIVED A $30,000 AWARD FOR ITS INITIATIVE OF TRANSITIONING TO AN OPIOID-LIGHT EMERGENCY DEPARTMENT. THE TWO FINALISTS, STRAUB MEDICAL CENTER IN HONOLULU AND UNIVERSITY OF FLORIDA IN GAINESVILLE, EACH RECEIVED $10,000 FOR THEIR RESPECTIVE PROGRAMS. THE RECIPIENT AND FINALISTS WERE RECOGNIZED DURING THE 2018 ASHP MIDYEAR CLINICAL MEETING IN ANAHEIM, CA. THE ASHP FOUNDATION, WITH SUPPORT FROM ASHP, SPONSORED A NATIONAL RADIO MEDIA TOUR AIMED AT EDUCATING CONSUMERS ABOUT THE VITAL ROLE OF HEALTH-SYSTEM PHARMACISTS. THE RADIO MEDIA TOUR FOCUSED ON HOW TO MANAGE YOUR PAIN SAFELY AND SUCCESSFULLY. CLINICAL PHARMACY MANAGER, DAWN WADDELL, PHARM.D., BCPS WITH BAPTIST MEMORIAL HOSPITAL MEMPHIS, THE RECIPIENT OF THE 2018 AWARD FOR EXCELLENCE IN MEDICATION SAFETY, JOINED US AS OUR PHARMACY EXPERT FOR 18 INTERVIEWS THAT REACHED OVER 13 MILLION LISTENERS. SHE ALSO RECORDED A PUBLIC SERVICE ANNOUNCEMENT.EACH AWARDEE WILL ALSO PRESENT AN EDUCATIONAL WEBINAR ON A RESIDENT PROFESSIONAL DEVELOPMENT TOPIC THAT CONTINUING EDUCATION CREDITS. THE WEBINARS WERE RECORDED AND MADE AVAILABLE FOR ON-DEMAND ACCESS. THE WEBINARS ARE RECORDED AND MADE AVAILABLE FOR ON-DEMAND ACCESS.PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAMTHE 2018 PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM WAS SUPPORTED AGAIN BY AMGEN, INC. THIS UNIQUE AWARD RECOGNIZES EXCELLENCE AND LEADERSHIP IN THE TRAINING AND MENTORING OF PHARMACY RESIDENTS. THE PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM RECOGNIZES A PRECEPTOR, NEW PRECEPTOR AND PROGRAM. THE OBJECTIVES OF THIS PROGRAM ARE TO: 1) RECOGNIZE THE ACHIEVEMENTS OF RESIDENCY PROGRAMS AND PHARMACISTS WHO HAVE DEMONSTRATED EXCELLENCE AND LEADERSHIP IN THE TRAINING OF PHARMACY RESIDENTS AND 2) WIDELY DISSEMINATE THE RESULTS OF THESE ACCOMPLISHMENTS TO FOSTER INNOVATIONS IN PHARMACY RESIDENT TRAINING. EACH AWARDEE WILL ALSO PRESENT AN EDUCATIONAL WEBINAR ON A RESIDENT PROFESSIONAL DEVELOPMENT TOPIC THAT CONTINUING EDUCATION CREDITS. THE WEBINARS ARE RECORDED AND MADE AVAILABLE FOR ON-DEMAND ACCESS. THE 2018 PROGRAM AND THE RECIPIENTS WERE:NEW PRECEPTOR: EMILY KOSIROG, PHARM.D., UNIVERSITY OF COLORADO SKAGGS SCHOOL OF PHARMACY, AURORA, COPRECEPTOR: LISA HALL ZIMMERMAN, PHARM.D., BCPS, BCNSP, HANOVER REGIONAL MEDICAL CENTER, WILMINGTON, NCPROGRAM: METHODIST UNIVERSITY HOSPITAL POSTGRADUATE YEAR ONE PHARMACY PRACTICE RESIDENCY, MEMPHIS, TNLITERATURE AWARDS PROGRAMTHE ASHP FOUNDATION LITERATURE AWARDS PROGRAM RECOGNIZES IMPORTANT CONTRIBUTIONS TO THE BIOMEDICAL LITERATURE BY PHARMACISTS. THIS PROGRAM, ADMINISTERED BY THE ASHP FOUNDATION SINCE 1971, IS BASED ON THE CONCEPT THAT RECOGNITION THROUGH AWARDS STIMULATES RESEARCH AND INNOVATION AND FOSTERS IMPROVEMENT IN THE QUALITY OF THE EVIDENCE. AWARDEES ARE RECOGNIZED AT THE ASHP MIDYEAR CLINICAL MEETING DURING THE SPOTLIGHT ON SCIENCE PLENARY SESSION. THE 2018 RECIPIENTS WERE: SUSTAINED CONTRIBUTIONSRHONDA M. COOPER-DEHOFF, PHARM.D., M.S., ASSOCIATE PROFESSOR, UNIVERSITY OF FLORIDA, GAINESVILLE, FLPHARMACY PRACTICE RESEARCH "DEVELOPMENT AND VALIDATION OF A COMPLEXITY SCORE TO RANK HOSPITALIZED PATIENTS AT RISK FOR PREVENTABLE ADVERSE DRUG EVENTS"AM J HEALTH SYST PHARM. 2017 DEC 1;74ALMUT WINTERSTEIN, PH.D., BEN STALEY, PHARM.D., CARL HENRIKSEN, M.S., DANDAN XU, M.S., PH.D., GLORIA LIPORI, M.B.A. , NAKYUNG JEON, B.S.PHARM., M.P.H., YOONYOUNG CHOI, B.S.PHARM., M.S., YAN LI, B.S.PHARM., M.S., JUAN HINCAPIE-CASTILLO, PHARM.D., RENE SORIA-SAUCEDO, M.D., M.P.H., PH.D., BABETTE BRUMBACK,INNOVATION IN PHARMACY PRACTICE"MEDICATION THERAPY DISEASE MANAGEMENT: GEISINGER'S APPROACH TO POPULATION HEALTH MANAGEMENT"AM J HEALTH-SYST PHARM. 2017; 74LANEY JONES, PHARM.D., MPH, GERARD GRESKOVIC, B.S.PHARM., DANTE M. GRASSI, PHARM.D., JOVE GRAHAM, PH.D., HAIYAN SUN, M.S., MICHAEL R. GIONFRIDDO, PHARM.D., PH.D., MICHAEL F. MURRAY, M.D., KANDAMURUGU MANICKAM, M.D., M.P.H., DOUGLAS C. NATHANSON, M.D., ERIC A. WRIGHT, PHARM.D., M.P.H., MICHAEL A. EVANS, B.S.PHARM.DRUG THERAPY RESEARCH CLINICAL ASSISTANT PROFESSOR, UNIVERSITY OF TEXAS AT AUSTIN, COLLEGE OF PHARMACY"PREGABALIN AND GABAPENTIN ABUSE: A SYSTEMATIC REVIEW"DRUGS 2017;77KIRK EVOY, PHARM.D., MEGAN D. MORRISON, PHARM.D., STEPHEN R. SAKLAD, PHARM.D.STUDENT RESEARCH AWARD"OUTCOMES OF PATIENTS WITH ATRIAL FIBRILLATION NEWLY RECOMMENDED FOR ORAL ANTICOAGULATION UNDER THE 2014 AMERICAN HEART ASSOCIATION/ AMERICAN COLLEGE OF CARDIOLOGY/HEART RHYTHM SOCIETY GUIDELINE"J AM HEART ASSOC. 2018;7MATTHEW P. GRAY, PHARM.D., PHD. STUDENT, SAMIR SABA, M.D., YUTING ZHANG, PH.D., INMACULADA HERENANDEZ, PHARM.D., PH.D.IN FY19, THE FOUNDATION ADMINISTERED TWO TRAINEESHIPS. CRITICAL CARE TRAINEESHIP THE CRITICAL CARE TRAINEESHIP INCLUDED A DISTANCE EDUCATION COMPONENT BEGINNING DECEMBER 2018, AN EXPERIENTIAL TRAINING COMPONENT, AND A POST-TRAINEESHIP PROJECT COMPONENT, WHICH WAS SUPPORT THROUGH PARTICIPANT TUITION. IN FY19, 5 PHARMACISTS WERE ACCEPTED INTO THE TRAINEESHIP, CONDUCTING THEIR DISTANCE EDUCATION BEGINNING DECEMBER 2018 AND GOING ONSITE FOR THEIR EXPERIENTIAL TRAINING SPRING OF 2019 AT UNIVERSITY OF TENNESSEE, CLEVELAND CLINIC, UC HEALTH UNIVERSITY OF CINCINNATI HOSPITAL, UNIVERSITY OF PITTSBURGH, AND BANNER HEALTH UNIVERSITY MEDICAL CENTER. TWO OF THE PARTICIPANTS APPLIED FOR AND RECEIVED A PARTIAL SCHOLARSHIP, WHICH REDUCED THEIR TUITION BY $1,000. PAIN AND PALLIATIVE CARE TRAINEESHIP THE PAIN AND PALLIATIVE CARE TRAINEESHIP INCLUDED ACCESS TO THE ASHP PAIN MANAGEMENT CERTIFICATE AND LIVE CASE-BASED WEBINARS, AN EXPERIENTIAL TRAINING COMPONENT, AND A POST-TRAINEESHIP PROJECT COMPONENT, WHICH WAS SUPPORTED THROUGH PARTICIPANT TUITION. IN FY19, 15 PHARMACISTS WERE ACCEPTED INTO THE TRAINEESHIP, CONDUCTING THEIR DISTANCE EDUCATION BEGINNING DECEMBER 2018 AND GOING ONSITE FOR THEIR EXPERIENTIAL TRAINING IN SPRING OF 2019 AT JOHN HOPKINS HOSPITAL, THE UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY, UNIVERSITY OF IOWA HOSPITALS AND CLINICS AND SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE SCHOOL OF PHARMACY. NINE OF THE PARTICIPANTS APPLIED FOR AND RECEIVED A PARTIAL SCHOLARSHIP, WHICH REDUCED THEIR TUITION AMOUNT BY $1,000. JOE A. ODDIS ETHICS COLLOQUIUMTHE COLLOQUIUM WAS ESTABLISHED TO PAY TRIBUTE TO ONE OF PHARMACY'S MOST DISTINGUISHED LEADERS AND ASSIST HEALTH-SYSTEM PHARMACISTS IN CONFRONTING ETHICAL CHALLENGES IN PHARMACY PRACTICE AND PATIENT CARE. THE 2018 COLLOQUIUM WAS OFFERED AS A LIVE EDUCATIONAL ACTIVITY PLANNED FOR THE 2018 ASHP SUMMER MEETINGS.

4b	(Code: ) (Expenses $ 621,717 including grants of $ 223,342 ) (Revenue $ 512,137 )
	INNOVATIVE RESEARCH: SUPPORT HEALTH SERVICES RESEARCH THAT FOSTER INNOVATION IN PHARMACY PRACTICE, WHICH PROMOTES THE OPTIMAL, SAFE AND EFFECTIVE USE OF MEDICATION.AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION (AFPE) PRE-DOCTORAL FELLOWSHIP THE ASHP FOUNDATION PROVIDED ANNUAL FUNDING OF $7,500 FOR THE AFPE PRE-DOCTORAL FELLOWSHIP PROGRAM. PHARMACY RESIDENT PRACTICE-BASED RESEARCH GRANT PROGRAM THIS GRANT PROGRAM IS FUNDED THROUGH THE ASHP MEMBER DUES CONTRIBUTION TO THE FOUNDATION. A SIX-MEMBER EXTERNAL PEER REVIEW PANEL RECOMMENDED AWARDING 8 GRANTS UP TO $5,000 EACH FOR:"MULTICENTERED RETROSPECTIVE REVIEW OF ANTIBIOTIC PRESCRIBING PATTERNS FOR TREATMENT OF URINARY TRACT INFECTIONS IN APRIMARY CARE SETTING"SARAH VISINTAINER NORTHEASTERN UNIVERSITY, BOSTON, MA"EFFECT OF A PHARMACIST-LED DIETARY SODIUM RESTRICTION EDUCATION INTERVENTION ON BLOOD PRESSURE, SODIUM KNOWLEDGE, AND SELF-EFFICACY IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HYPERTENSION" KATHERINE CHO MICHIGAN MEDICINE, ANN ARBOR, MI"ADVANCING THE PHARMACIST'S ROLE IN PREVENTING HEALTHCARE FACILITY-ONSET C. DIFFICILE: EXPANSION OF A RISK PREDICTION MODEL"CARRIE TILTON EMORY UNIVERSITY HOSPITAL, ATLANTA, GA"IMPLEMENTATION OF A PHARMACIST-DRIVEN KIDNEY ACTION PLAN TO DECREASE RISK OF CHRONIC KIDNEY DISEASE DEVELOPMENT OR PROGRESSION IN ACUTE KIDNEY INJURY SURVIVORS" DIANA SCHREIER MAYO CLINIC, ROCHESTER, MNJENNA FANCHER PROJECT PACT-STROKE: PHARMACISTS ACT ON CARE TRANSITIONS-STROKE UPSTATE UNIVERSITY HOSPITAL & ST. JOHN FISHER WEGMANS SCHOOL OF PHARMACY, SYRACUSE, NYANNE WILLIAMS QUANTIFYING THE VALUE OF PHARMACISTS PROVIDING DIRECT PATIENT CARE WITHIN FAMILY MEDICINE PRACTICES UPMC ST. MARGARET, PITTSBURGH, PA"UTILIZATION OF GAP ANALYSIS TO ASSESS CONTROLLED SUBSTANCE MANAGEMENT AT AN ACADEMIC MEDICAL CENTER" BAILEY EASONWAKE FOREST BAPTIST MEDICAL CENTER, WINSTON-SALEM, NC"IMPACT OF A COMMUNITY PHARMACY-BASED CDTM PROGRAM SUPPORTED BY A MEDICATION SYNCHRONIZATION PROGRAM"CAITLIN PRATHER AUBURN UNIVERSITY HARRISON SCHOOL OF PHARMACY, AUBURN, ALPHARMACY PRACTICE ADVANCEMENT DEMONSTRATION GRANTTWENTY LETTERS OF INTENT AND 9 FULL APPLICATIONS WERE REVIEWED BY EXTERNAL REVIEW PANEL IN ORDER TO AWARD THE FY19 GRANTEES. THIS RESEARCH GRANT PROGRAM SUPPORTS DEMONSTRATION PROJECTS RELATED TO PRACTICE ADVANCEMENT, CONSISTENT WITH THE ASHP/ASHP FOUNDATION PRACTICE ADVANCEMENT INITIATIVE (PAI) AND AMBULATORY PAI. GRANT FUNDS WERE PROVIDED BY THE HENRI R. MANASSE LEGACY FUND AND EACH GRANTEE WAS AWARDED UP TO $75,000. "EVALUATION OF A PHARMACIST-DIRECTED PERSONALIZED CANCER MEDICINE CLINICAL SERVICE AND DEVELOPMENT OF TOOLS ALONG WITH BEST PRACTICES TO SUPPORT PHARMACIST ADOPTION" INVESTIGATOR: J. KEVIN HICKS, PHARM.D., PH.D.H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE, TAMPA, FL"IMPLEMENTING A PHARMACIST-MANAGED PERSONALIZED MEDICINE DOSING PROTOCOL FOR BETA-LACTAM ANTIBIOTICS IN CRITICALLY ILL PATIENTS: A PROSPECTIVE OBSERVATIONAL, SEQUENTIAL PERIOD, PILOT STUDY"INVESTIGATOR: MELISSA L. THOMPSON-BASTIN, PHARM.D., B.S., BCPS UNIVERSITY OF KENTUCKY, LEXINGTON, KYNEW PRACTITIONER PHARMACIST LEADERSHIP DEVELOPMENT RESEARCH GRANT PROGRAM THIS NEW GRANT PROGRAM, FUNDED THROUGH THE MARIANNE F. IVEY LEADERSHIP DEVELOPMENT FUND, AWARDS NEW PRACTITIONER PHARMACISTS TO SUPPORT DIVERSE PROJECTS RELATED TO LEADERSHIP DEVELOP RESEARCH. AREAS OF FOCUS INCLUDE, MODEL DEMONSTRATION PROJECTS, SYSTEMS CHANGE PROJECTS, SPECIAL STUDIES AND EVALUATIONS THAT ARE FOCUSED ON DEVELOPING LEADERSHIP COMPETENCIES. A SIX-MEMBER EXTERNAL PEER REVIEW PANEL RECOMMENDED AWARDING 5 GRANTS UP TO $5,000 EACH FOR:"SYSTEMIZATION AND EVALUATION OF THE IMPACT OF A PHARMACY TECHNICIAN LADDER IN A MULTI-HOSPITAL SYSTEM"SUNNY BHAKTA HOUSTON METHODIST HOSPITAL, HOUSTON, TX"RESPONSE AMONG U.S. HOSPITAL PHARMACY DIRECTORS AND DEPARTMENTS"MATTHEW BILHIMER UNIVERSITY OF ROCHESTER MEDICAL CENTER, ROCHESTER, NY"CHARACTERIZING AND ADDRESSING BURNOUT AMONG FULL-TIME PHARMACISTS EMPLOYED WITHIN A MULTI-HOSPITAL HEALTH SYSTEM"TARA FELLER THE JOHNS HOPKINS HOSPITAL, BALTIMORE, MD"ASSESSMENT OF TURNOVER, RESILIENCE, AND WELL-BEING OF PHARMACY DEPARTMENT EMPLOYEES AT AN ACADEMIC MEDICAL CENTER"ELISSA KING UNIVERSITY OF NORTH CAROLINA HOSPITALS, CHAPEL HILL, NC"EVALUATING EMPATHY AND BURNOUT IN STUDENT PHARMACISTS"MEGAN EALEY AUBURN UNIVERSITY, AUBURN, ALNEW INVESTIGATOR RESEARCH GRANT FOURTEEN LETTERS OF INTENT AND 6 FULL APPLICATIONS WERE REVIEWED BY AN EXTERNAL PANEL IN ORDER TO AWARD THE FY19 GRANTEES. GRANT FUNDS ARE PROVIDED BY THE ASHP FOUNDATION THROUGH THE ABBOTT ENDOWMENT AND EACH GRANTEE RECEIVED UP TO $20,000. "IMPACT OF A PHARMACIST-DRIVEN COLLABORATIVE INITIATIVE FOR STAPHYLOCOCCUS AUREUS BACTEREMIA MANAGEMENT"WESLEY KUFEL, PHARM.D., BCPS, AAHIVPBINGHAMTON UNIVERSITY SCHOOL OF PHARMACY AND PHARMACEUTICAL SCIENCES, BINGHAMTON, NY"EFFECTIVENESS OF PHARMACIST-DRIVEN DIURESIS IN THE INTENSIVE CARE UNIT"BRITTANY BISSELL, PHARM.D.UNIVERSITY OF KENTUCKY MEDICAL CENTER, LEXINGTON, KYRESEARCH ADVISORY PANELTHE RESEARCH ADVISORY PANEL (RAP) WAS PUT ON HOLD AS THE ASHP FOUNDATION BOARD ENGAGED IN STRATEGIC PLANNING DURING FY19.PHARMACY FORECAST REPORT 2019THE 2019 PHARMACY FORECAST REPORT WAS SUPPORTED BY A GRANT FROM OMNICELL, INC., TO THE ASHP FOUNDATION'S DAVID A. ZILZ LEADERS FOR THE FUTURE FUND AND WAS PUBLISHED IN AJHP IN THE JANUARY 15, 2019 ISSUE. THE DISTRIBUTION OF THE FORECAST REPORT IN AJHP ENSURED THAT IT WAS MADE AVAILABLE TO ALL 50,000 ASHP MEMBERS. IT WAS PUBLISHED ELECTRONICALLY IN DECEMBER 2018 AND PRESENTED AT AN EDUCATIONAL SESSION DURING THE 2018 ASHP MIDYEAR CLINICAL MEETING. THE REPORT GENERATED AUTHORITATIVE, ACTIONABLE STRATEGIC RECOMMENDATIONS TO ENHANCE THE EFFECTIVENESS OF LEADERS IN HOSPITAL AND HEALTH-SYSTEM PHARMACY.

4c	(Code: ) (Expenses $ including grants of $ ) (Revenue $ )












4d	Other program services (Describe in Schedule O.)
	(Expenses $ including grants of $ ) (Revenue $ )
4e	Total program service expenses1,676,202

1b	Sub-Total................
c	Total from continuation sheets to Part VII, Section A....
d	Total (add lines 1b and 1c)...........	786,526	890,257	205,338

(A) Name and business address	(B) Description of services	(C) Compensation





2 Total number of independent contractors (including but not limited to those listed above) who received more than $100,000 of compensation from the organization 0

1a	Federated campaigns..		1a
b	Membership dues..		1b
c	Fundraising events..		1c
d	Related organizations		1d	365,756
e	Government grants (contributions)		1e

f	All other contributions, gifts, grants, and similar amounts not included above		1f	1,402,846

g	Noncash contributions included in lines 1a - 1f:$ 100,700
h Total. Add lines 1a-1f.......		1,768,602

		Business Code
2a	PHARMACY LEADERSHIP AC	611430	439,700	439,700
b	PAIN & PALLIATIVE TRAI	611430	38,812	38,812
c	CRITICAL CARE TRAINEES	611430	33,625	33,625
d
e
f	All other program service revenue.
g	Total. Add lines 2a–2f ....		512,137

3 Investment income (including dividends, interest, and othersimilar amounts) ......			406,338			406,338
4 Income from investment of tax-exempt bond proceeds
5 Royalties...........
		(ii) Personal	(i) Real
6a	Gross rents
b	Less: rental expenses
c	Rental income or (loss)
d	Net rental income or (loss)......
		(ii) Other	(i) Securities
7a	Gross amount from sales of assets other than inventory		992,147
b	Less: cost or other basis and sales expenses		914,756
c	Gain or (loss)		77,391
d	Net gain or (loss).....			77,391			77,391
8a	Gross income from fundraising events (not including $ of contributions reported on line 1c). See Part IV, line 18 ....
	a
b	Less: direct expenses ...b
c	Net income or (loss) from fundraising events..
9a	Gross income from gaming activities. See Part IV, line 19 ...
	a
b	Less: direct expenses ...b
c	Net income or (loss) from gaming activities..
10a	Gross sales of inventory, less returns and allowances ..
	a
b	Less: cost of goods sold ..b
c	Net income or (loss) from sales of inventory..
Business Code			Miscellaneous Revenue
11a
b
c
d	All other revenue ....
e	Total. Add lines 11a–11d ......
12	Total revenue. See Instructions......			2,764,468	512,137	0	483,729

1	Grants and other assistance to domestic organizations and domestic governments. See Part IV, line 21	438,370	438,370
2	Grants and other assistance to domestic individuals. See Part IV, line 22	38,500	38,500
3	Grants and other assistance to foreign organizations, foreign governments, and foreign individuals. See Part IV, line 15 and 16.
4	Benefits paid to or for members
5	Compensation of current officers, directors, trustees, and key employees ....	426,657	208,255	30,465	187,937
6	Compensation not included above, to disqualified persons (as defined under section 4958(f)(1)) and persons described in section 4958(c)(3)(B) ....
7	Other salaries and wages	746,684	355,246	50,706	340,732
8	Pension plan accruals and contributions (include section 401(k) and 403(b) employer contributions) ....	96,232	57,059	5,324	33,849
9	Other employee benefits .......	75,512	42,161	8,453	24,898
10	Payroll taxes ...........	66,813	37,655	5,061	24,097
11	Fees for services (non-employees):
a	Management ......
b	Legal .........
c	Accounting ...........	12,500		12,500
d	Lobbying ...........
e	Professional fundraising services. See Part IV, line 17
f	Investment management fees ......
g	Other (If line 11g amount exceeds 10% of line 25, column (A) amount, list line 11g expenses on Schedule O)	491,079	378,992	71,884	40,203
12	Advertising and promotion ....
13	Office expenses .......	48,592	40,008	6,723	1,861
14	Information technology ......
15	Royalties ..
16	Occupancy ...........
17	Travel ............	123,964	64,456	25,827	33,681
18	Payments of travel or entertainment expenses for any federal, state, or local public officials .
19	Conferences, conventions, and meetings ....
20	Interest ...........
21	Payments to affiliates .......
22	Depreciation, depletion, and amortization ..	2,280		2,280
23	Insurance ...
24	Other expenses. Itemize expenses not covered above (List miscellaneous expenses in line 24e. If line 24e amount exceeds 10% of line 25, column (A) amount, list line 24e expenses on Schedule O.)
a	GENERAL EXPENSES	26,138	15,500	1,426	9,212
b
c
d
e	All other expenses
25	Total functional expenses. Add lines 1 through 24e	2,593,321	1,676,202	220,649	696,470
26	Joint costs. Complete this line only if the organization reported in column (B) joint costs from a combined educational campaign and fundraising solicitation. Check here if following SOP 98-2 (ASC 958-720).

1	Cash–non-interest-bearing ........			127,598	1	81,749
2	Savings and temporary cash investments .........			307,144	2	189,363
3	Pledges and grants receivable, net ......			629,402	3	602,196
4	Accounts receivable, net .............				4
5	Loans and other receivables from current and former officers, directors, trustees, key employees, and highest compensated employees. Complete Part II of Schedule L .............
					5
6	Loans and other receivables from other disqualified persons (as defined under section 4958(f)(1)), persons described in section 4958(c)(3)(B), and contributing employers and sponsoring organizations of section 501(c)(9) voluntary employees' beneficiary organizations (see instructions) Complete Part II of Schedule L ..............
					6
7	Notes and loans receivable, net ....				7
8	Inventories for sale or use ........				8
9	Prepaid expenses and deferred charges ......			39,322	9	242,712
10a	Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D	10a	83,984
b	Less: accumulated depreciation	10b	72,586	0	10c	11,398
11	Investments—publicly traded securities .			8,839,121	11	8,971,882
12	Investments—other securities. See Part IV, line 11 .....			208,069	12	161,768
13	Investments—program-related. See Part IV, line 11 ..				13
14	Intangible assets ...............				14
15	Other assets. See Part IV, line 11 ...........			15,018	15	15,018
16	Total assets. Add lines 1 through 15 (must equal line 34)...			10,165,674	16	10,276,086

17	Accounts payable and accrued expenses .....	249,143	17	277,949
18	Grants payable ...		18
19	Deferred revenue .........	322,049	19	576,262
20	Tax-exempt bond liabilities .........		20
21	Escrow or custodial account liability. Complete Part IV of Schedule D		21
22	Loans and other payables to current and former officers, directors, trustees, key employees, highest compensated employees, and disqualified
	persons. Complete Part II of Schedule L..		22
23	Secured mortgages and notes payable to unrelated third parties ..		23
24	Unsecured notes and loans payable to unrelated third parties ..		24
25	Other liabilities (including federal income tax, payables to related third parties, and other liabilities not included on lines 17 - 24). Complete Part X of Schedule D		25
26	Total liabilities. Add lines 17 through 25..	571,192	26	854,211

	Organizations that follow SFAS 117 (ASC 958), check here and complete lines 27 through 29, and lines 33 and 34.
27	Unrestricted net assets	1,098,658	27	1,471,468
28	Temporarily restricted net assets ...........	3,405,634	28	2,858,737
29	Permanently restricted net assets	5,090,190	29	5,091,670
	Organizations that do not follow SFAS 117 (ASC 958), check here and complete lines 30 through 34.
30	Capital stock or trust principal, or current funds .....		30
31	Paid-in or capital surplus, or land, building or equipment fund ...		31
32	Retained earnings, endowment, accumulated income, or other funds		32
33	Total net assets or fund balances ...........	9,594,482	33	9,421,875
34	Total liabilities and net assets/fund balances ........	10,165,674	34	10,276,086